<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta charset="utf-8" />
		<title>BCSC2017-2018_S08_ch07_p133-172</title>
		<link href="BCSC2017-2018_S08_ch07_p133-172-web-resources/css/idGeneratedStyles.css" rel="stylesheet" type="text/css" />
	</head>
	<body id="BCSC2017-2018_S08_ch07_p133-172" lang="en-US">
		<div id="_idContainer000" class="Basic-Text-Frame">
			<p class="chapter-number"><span class="cn-chap">Chapter </span>7</p>
			<p class="chapter-title">Corneal Dystrophies and Ectasias</p>
			<p class="h1 ParaOverride-1">Highlights</p>
			<div id="Chapt7_Top1">
			<ul>
				<li class="bullet-list-mid">Recurrent erosions are typical of the keratoepithelin dystrophies affecting the epithelial basement membrane complex.</li>
				<li class="bullet-list-mid">Genetic analysis has dramatically reshaped our understanding of the corneal dystrophies.</li>
				<li class="bullet-list-mid">The location of stromal thinning relative to the area of corneal protrusion is important for identifying the specific ectatic disorder.</li>
			</ul>
			</div>
			<p class="h1 ParaOverride-2">Corneal Dystrophies</p>
		    <div id="Chapt7_Top2">
			<p class="h2-h1">General Considerations</p>
			<p class="body-text--no-indent-"><span class="italic">Corneal dystrophies</span> are commonly defined as bilateral, symmetric, inherited conditions that appear to have little or no relationship to environmental or systemic factors. Dystrophies begin early in life, are slowly progressive, increase with age, and may not become clinically apparent until years later. They are often characterized by the progressive accumulation of deposits. These deposits result from genetic mutations that lead to transcription of aberrant proteins. Mutations in the transforming growth factor beta–induced gene <span class="italic">(TGFBI),</span> which leads to production of the keratoepithelin protein, are an important example.</p>
			<p class="body-text">Many patients with corneal dystrophies associated with deposits present with symptoms of recurrent corneal erosion or blurred vision due to either irregular astigmatism or stromal opacification. This is particularly true when the pathology is more superficial, encroaching on the epithelial basement membrane complex. However, there are patients who experience blurred vision because of corneal edema (eg, as in Fuchs endothelial corneal dystrophy) or because of dystrophies not associated with deposits (eg, epithelial basement membrane dystrophy); the latter example may in fact be a degeneration rather than a dystrophy. In general, these conditions are in the process of redefinition and recharacterization.</p>
			<p class="body-text">To more accurately reflect the evolving genetic, clinical, and histologic characteristics of the dystrophies, the International Committee for the Classification of Corneal Dystrophies (IC3D) revised the dystrophy nomenclature. In this reclassification, recently updated, each dystrophy is classified into 1 of 4&#160;groups: epithelial and subepithelial dystrophies, epithelial–stromal <span class="italic">TGFBI</span> dystrophies, stromal dystrophies, and endothelial dystrophies. The dystrophies are described according to a template consisting of clinical, pathologic, and genetic information. The system is upgradable and can be retrieved at www.corneasociety.org.</p>
			<p class="body-text">In addition, the strength of evidence for each dystrophy is described using 1 of 4&#160;assigned categories (<span class="xref-table">Table&#160;7-1</span>). The category assignment may change as more information about an individual dystrophy is obtained. It is hoped that, over time, all valid corneal dystrophies will attain category 1&#160;status. The IC3D classification of major corneal dystrophies is summarized in <span class="xref-table">Table&#160;7-2.</span> A fairly comprehensive treatment of all corneal dystrophies is available in the IC3D publication and is beyond the scope of the BCSC. This chapter provides a basic discussion of the more common dystrophies for which there is the best evidence.</p>
			<p class="body-text">The genetics of major corneal dystrophies is summarized in <span class="xref-table">Table&#160;7-3</span>. Although learning the genetics of each dystrophy is not critical to developing a basic understanding of these diseases, it is important to appreciate the significance of particular genetic mutations. For example, mutations in the <span class="italic">TGFBI</span> gene lead to most of the stromal corneal dystrophies associated with recurrent corneal erosions. In addition, there are dystrophies that appear the same phenotypically but differ genetically; conversely, dystrophies due to mutations in the same gene may have different phenotypes.</p>
			<p class="body-text">During the clinical examination, the ophthalmologist is encouraged to consider the following questions to determine whether a dystrophy is present and to differentiate between the corneal dystrophies:</p>
			<ul>
				<li class="bullet-list-first ParaOverride-3">Are other family members affected?</li>
				<li class="bullet-list-mid">Are there signs of inflammation (eg, stromal cells or neovascularization)? If so, the condition may not be a dystrophy.</li>
				<li class="bullet-list-mid">Are the corneal opacities in both eyes and, if so, are they symmetric or asymmetric?</li>
				<li class="bullet-list-mid">In which corneal layer(s) do the opacities appear?</li>
				<li class="bullet-list-mid">Are there clear zones between the lesions?</li>
				<li class="bullet-list-mid">Do the lesions extend to the limbus?</li>
				<li class="bullet-list-mid">Is the cornea abnormally thick, thin, or of normal thickness?</li>
				<li class="bullet-list-last">Is the morphology of the lesions suggestive of a corneal dystrophy?</li>
			</ul>
			<p class="body-text--no-indent-">Obtaining a family history is essential. Examination of biological relatives who have accompanied the patient to the office may be revealing, and genetic testing of the patient or affected family members may also be helpful.</p>
			<p class="body-text">For further discussion of genetics, see the genetics section in BCSC Section&#160;2, <span class="italic">Fundamentals and Principles of Ophthalmology.</span> See also Section&#160;4, <span class="italic">Ophthalmic Pathology and Intraocular Tumors,</span> Chapter&#160;6.</p>
			<p class="reference-single--no-space-">Weiss JS, Møller HU, Aldave AJ, et al. IC3D classification of corneal dystrophies—edition 2. <span class="italic">Cornea.</span> 2015;34(2):117–159.</p>
			<p class="h2 ParaOverride-4">Epithelial and Subepithelial Dystrophies</p>
			<p class="h3-h2 ParaOverride-5">Epithelial basement membrane dystrophy (EBMD)</p>
			<p class="h4-text"><span class="h4-head">Alternative names</span> Map-dot-&#173;fingerprint dystrophy, Cogan microcystic epithelial dystrophy, anterior basement membrane dystrophy</p>
			<p class="h4-text"><span class="h4-head">Inheritance</span> No well-&#173;documented inheritance; may be degenerative</p>
			<p class="h4-text"><span class="h4-head">Category</span> Most cases are sporadic; however, category&#160;1 in rare cases</p>
			<p class="h5-text"><span class="h5-head">pathology</span> EBMD is an abnormality of epithelial turnover, maturation, and production of basement membrane. Histologic findings include the following:</p>
			<ul>
				<li class="bullet-list-first ParaOverride-6">sheets of intraepithelial, multilamellar basal lamina material (maps)</li>
				<li class="bullet-list-mid">intraepithelial extension of basal laminar material (fingerprint lines)</li>
				<li class="bullet-list-mid">intraepithelial pseudocysts containing cytoplasmic debris (dots)</li>
				<li class="bullet-list-last ParaOverride-7">irregular, subepithelial accumulation of fibrogranular material (bleb)</li>
			</ul>
			<p class="h5-text"><span class="h5-head">clinical presentation</span> Epithelial basement membrane dystrophy occurs in 6%–18% of the population, more commonly in women, with increasing frequency in patients older than 50&#160;years. Gray patches, pseudocysts, and/or fine lines in the corneal epithelium are noted on examination and are best seen by using a broad oblique slit-lamp beam or with retroillumination. (See Chapter&#160;2 for a discussion of slit-lamp biomicroscopy.) The clinician can also identify EBMD by using the sclerotic scatter illumination technique or by using the slit lamp with a cobalt-&#173;blue filter after instilling fluorescein. Four kinds of patterns are seen:</p>
			<ul>
				<li class="bullet-list-first ParaOverride-6">fingerprint lines</li>
				<li class="bullet-list-mid">maps</li>
				<li class="bullet-list-mid">dots</li>
				<li class="bullet-list-last ParaOverride-8">bleb pattern (Bron)</li>
			</ul>
			<p class="body-text--no-indent-">These abnormalities occur in varying combinations and can change in number and distribution over time. <span class="italic">Fingerprint lines</span> are thin, relucent, parallel, hairlike lines; several of them can be arranged in a concentric pattern so that they resemble fingerprints or a horse’s tail. <span class="italic">Maps</span> are geographic, irregular coastlines or islands of thickened, gray, hazy epithelium with scalloped, circumscribed borders (<span class="xref-figure">Fig&#160;7-1</span>). <span class="italic">Dots</span> are irregular round, oval, or comma-&#173;shaped intraepithelial opacities containing the debris of epithelial cells that collapsed and degenerated before reaching the epithelial surface (<span class="xref-figure">Fig&#160;7-2</span>). The <span class="italic">bleb pattern (Bron)</span> resembles pebbled glass and is best seen with retroillumination. The gray-white dots have discrete edges.</p>
			<p class="body-text">Symptoms are typically related to recurrent epithelial erosions and/or blurred vision, ghosting, or monocular diplopia, and while more common in patients older than 30&#160;years, they can occur at any age. The impact of EBMD on vision correlates with the degree of surface disruption and induced irregular astigmatism, which can be detected on keratometry or corneal topography. Symptoms of recurrent erosions typically occur in the morning; however, discomfort in the morning may also occur in patients with nighttime lagophthalmos. Punctate erosions are usually noted in the inferior cornea in this setting. It is estimated that only 10% of patients with EBMD will have corneal erosions but that 50% of patients with recurrent epithelial erosions have evidence of this anterior dystrophy. Both eyes must be examined because evidence of the dystrophy may be found in the <br />uninvolved eye. Unilateral dystrophic changes may be related to focal trauma rather than a dystrophy. In some cases, clinical findings may mimic corneal intraepithelial dysplasia; therefore, consideration should be given to submitting removed material for histologic study.</p>
			<p class="h5-text ParaOverride-9"><span class="h5-head">management</span> Asymptomatic patients may not require treatment. For patients with irregular astigmatism, epithelial debridement may be necessary. See Chapter&#160;3 for a discussion of recurrent erosions.</p>
			<p class="h3 ParaOverride-5">Meesmann epithelial corneal dystrophy (MECD)</p>
			<p class="h4-text ParaOverride-10"><span class="h4-head">Variant</span> Stocker-Holt</p>
			<p class="h4-text ParaOverride-10"><span class="h4-head">Inheritance</span> Autosomal dominant (AD)</p>
			<p class="h4-text ParaOverride-10"><span class="h4-head">Category</span> 1 (including the Stocker-Holt variant)</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">pathology</span> Intraepithelial cysts consisting of degenerated epithelial cell products (cellular debris that is periodic acid–Schiff [PAS] positive and fluoresces) are present. The epithelial cells contain an electron-&#173;dense accumulation of fibrogranular material surrounded by tangles of cytoplasmic filaments (“peculiar substance”). There are frequent mitoses and a thickened basement membrane with projections into the basal epithelium; the basal epithelial cells have increased levels of glycogen. On confocal microscopy, hyporeflective areas ranging from 40 to 150&#160;µm in diameter are seen in the basal epithelium and contain potential reflective spots.</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">clinical presentation</span> Meesmann corneal dystrophy appears very early in life. Tiny intraepithelial vesicles are seen—most easily with retroillumination—extending to the limbus. These appear as minute bubblelike blebs (<span class="xref-figure">Fig&#160;7-3</span>). In 85% of eyes, the entire epithelium is affected. The epithelium surrounding the cyst is clear. Whorled and wedge-shaped epithelial patterns may be seen. The cornea may be slightly thinned, and corneal sensation may be reduced. Symptoms are usually limited to mild ocular irritation and a slight decrease in vision. Some patients report glare and light sensitivity. Painful recurrent erosions may occur.</p>
			<p class="body-text">The Stocker-Holt variant, which maps to a different gene, may have an earlier onset and demonstrate more severe signs and symptoms.</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">management</span> Most patients require no treatment, but soft contact lens wear may be helpful if symptoms are frequent.</p>
			<p class="h3">Lisch epithelial corneal dystrophy (LECD)</p>
			<p class="h4-text"><span class="h4-head">Inheritance</span> X-chromosomal dominant</p>
			<p class="h4-text"><span class="h4-head">Category</span> 2</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">pathology</span> Diffuse cytoplasmic vacuolization of affected cells, which are PAS positive, is seen in light and transmission electron microscopy. On immunohistochemistry, there is scattered staining on Ki67 without evidence of increased mitotic activity. Confocal microscopy shows highly reflective cytoplasm and hyporeflective nuclei.</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">clinical presentation</span> On direct slit-lamp examination, discrete sectorial, band-shaped and feathery gray lesions are seen in whorled, flame-shaped, or feathery patterns. Retroillumination reveals intraepithelial, densely crowded, clear microcysts (<span class="xref-figure">Fig&#160;7-4</span>). The surrounding epithelium is clear. In Meesmann dystrophy, such band-shaped, feathery lesions do not exist, and the corneal involvement is more diffuse. Also, the intraepithelial cysts of Meesmann dystrophy are not as densely crowded as in Lisch dystrophy but are isolated, with clear spaces between the cysts.</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">management</span> Patients with Lisch dystrophy are pain free. There may be an associated decrease in vision. Corneal debridement may be attempted but often results in recurrence. Contact lenses may be helpful for more severe cases. There is one case report on the successful treatment of Lisch dystrophy (one eye) using photorefractive keratectomy (PRK) with mitomycin.</p>
			<p class="reference-first ParaOverride-10">Alvarez-Fischer M, de Toledo JA, Barraquer RI. Lisch corneal dystrophy. <span class="italic">Cornea.</span> 2005;24(4):<br />494–495.</p>
			<p class="reference-mid">Lisch W, Büttner A, Oeffner F, et al. Lisch corneal dystrophy is genetically distinct from Meesmann corneal dystrophy and maps to xp22.3. <span class="italic">Am&#160;J Ophthalmol.</span> 2000;130(4):<br />461–468.</p>
			<p class="reference-last--no-space-">Wessel MM, Sarkar JS, Jakobiec FA, et al. Treatment of Lisch corneal dystrophy with photo&#173;refractive keratectomy and mitomycin&#160;C. <span class="italic">Cornea.</span> 2011;30(4):481–485.</p>
			<p class="h3 ParaOverride-11">Gelatinous droplike corneal dystrophy (GDLD)</p>
			<p class="h4-text ParaOverride-9"><span class="h4-head">Alternative names</span> Subepithelial amyloidosis, primary familial amyloidosis</p>
			<p class="h4-text ParaOverride-9"><span class="h4-head">Inheritance</span> Autosomal recessive (AR)</p>
			<p class="h4-text"><span class="h4-head">Category</span> 1</p>
			<p class="h5-text"><span class="h5-head">pathology</span> Light microscopy shows subepithelial and stromal amyloid deposits. Disruption of epithelial tight junctions leads to abnormally high epithelial permeability. Confocal microscopy shows irregular, elongated epithelial cells with large accumulations of brightly reflective material noted within or beneath the epithelium and within the anterior stroma. Amyloid deposition is noted in the basal epithelial layer on transmission electron microscopy. See also Chapter&#160;8 for discussion of amyloidosis.</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">clinical presentation</span> Onset occurs in the first to second decade of life with groups of multiple small nodules (mulberry configuration) or with subepithelial lesions that may appear similar to those of band keratopathy (<span class="xref-figure">Fig&#160;7-5A,&#160;B</span>). The lesions are visible on fluorescein staining. There is a significant decrease in vision, with photophobia, irritation, and tearing, as well as progression of protruding subepithelial lesions. Superficial vascularization is often seen. Stromal opacification or larger nodular lesions (kumquat-&#173;like lesions) may develop (Fig&#160;7-5C).</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">management</span> The lesions recur within a few years in all patients following superficial keratectomy, lamellar keratoplasty (LK), or penetrating keratoplasty (PK). Soft contact lenses are effective in reducing the abnormal epithelial permeability to decrease recurrences.</p>
			<p class="reference-single--no-space- ParaOverride-12">Ide T, Nishida K, Maeda N, et al. A spectrum of clinical manifestations of gelatinous drop-like corneal dystrophy in Japan. <span class="italic">Am&#160;J Ophthalmol.</span> 2004;137(6):1081–1084.</p>
			<p class="h2">Epithelial–Stromal <span class="h2--emph-">TGFBI</span> Dystrophies</p>
			<p class="h3-h2">Reis-Bücklers corneal dystrophy (RBCD)</p>
			<p class="h4-text ParaOverride-9"><span class="h4-head">Alternative names</span> Corneal dystrophy of Bowman layer type&#160;1 (CDB1), atypical granular corneal dystrophy</p>
			<p class="h4-text ParaOverride-9"><span class="h4-head">Inheritance</span> AD</p>
			<p class="h4-text ParaOverride-9"><span class="h4-head">Category</span> 1</p>
			<p class="h5-text"><span class="h5-head">pathology</span> On light microscopy, the Bowman layer is disrupted or absent and replaced by a sheetlike connective tissue layer with granular deposits that stain red with Masson trichrome stain. Transmission electron microscopy shows subepithelial electron-&#173;dense, rod-shaped bodies. The rod-shaped bodies are immunopositive for the <span class="italic">TGFBI</span> protein, keratoepithelin. Electron microscopy is needed to histologically distinguish RBCD from Thiel-&#173;Behnke corneal dystrophy (TBCD), which has curly fibers (see the next section). On confocal microscopy, distinct deposits are found in the epithelium and Bowman layer. The basal epithelial cell layer shows high reflectivity associated with small granular deposits without any shadows (<span class="xref-figure">Fig&#160;7-6A</span>), as is seen in TBCD. The Bowman layer is replaced with highly reflective irregular material. Greater hyperreflectivity is seen at the Bowman layer in RBCD than in TBCD.</p>
			<p class="h5-text"><span class="h5-head">clinical presentation</span> Reis-&#173;Bücklers corneal dystrophy appears in the first few years of life and mainly affects the Bowman layer. Confluent, irregular, and coarse geographic opacities with varying densities develop at the level of the Bowman layer and superficial stroma, mostly centrally (Fig&#160;7-6B). With time, the opacities may extend to the limbus and deeper stroma (Fig&#160;7-6C, D).</p>
			<p class="body-text">The posterior cornea appears normal. In advanced cases, stromal scarring can lead to surface irregularity. Symptoms often begin in the first or second decade of life with painful recurrent epithelial erosions. The erosions in RBCD are usually more severe and more frequent than those in TBCD, but they recur less often over time. Anterior scarring and associated surface irregularity both contribute to reduced vision.</p>
			<p class="h5-text ParaOverride-9"><span class="h5-head">management</span> Initial treatment is aimed at the recurrent erosions. Superficial keratectomy, LK, phototherapeutic keratectomy (PTK), or, in rare instances, PK may be performed. Recurrence in the graft is common.</p>
			<p class="reference-single--no-space- ParaOverride-10">Laibson PR. Anterior corneal dystrophies. In: Mannis MJ, Holland EJ, eds. <span class="italic">Cornea.</span> Vol&#160;1. 4th&#160;ed. Philadelphia: Elsevier; 2017:770–780.</p>
			<p class="h3 ParaOverride-13">Thiel-Behnke corneal dystrophy (TBCD)</p>
			<p class="h4-text"><span class="h4-head">Alternative names</span> Corneal dystrophy of Bowman layer type&#160;2 (CDB2), honeycomb-&#173;shaped corneal dystrophy, Waardenburg-&#173;Jonkers corneal dystrophy</p>
			<p class="h4-text ParaOverride-9"><span class="h4-head">Inheritance</span> AD</p>
			<p class="h4-text ParaOverride-9"><span class="h4-head">Category</span> 1 (<span class="italic">TGFBI</span> variant), 2 (10q24 variant)</p>
			<p class="h5-text ParaOverride-9"><span class="h5-head">pathology</span> Light microscopy shows irregular thickening and thinning of the epithelial layer, which offset the ridges and furrows in the underlying stroma and the focal absences of the epithelial basement membrane. The Bowman layer is replaced with fibrocellular material in a pathognomonic wavy, “sawtoothed” pattern. On electron microscopy, curly fibers (9–15&#160;nm) are apparent, distinguishing this dystrophy from RBCD. These curly fibers are immunopositive for the <span class="italic">TGFBI</span> protein, keratoepithelin, which is associated with the 5q31&#160;locus. On confocal microscopy, distinct deposits are found in the epithelium and Bowman layer. The deposits in the basal epithelial cell layer show reflectivity, with round edges and dark shadows not seen in RBCD (<span class="xref-figure">Fig&#160;7-7A</span>). The Bowman layer is replaced with irregular reflective material that is less reflective than in RBCD. Optical coherence tomography (OCT) shows hyperreflective material at the level of the Bowman layer in the characteristic sawtoothed configuration that also distinguishes TBCD from RBCD (Fig&#160;7-7B).</p>
			<p class="h5-text ParaOverride-9"><span class="h5-head">clinical presentation</span> Onset is in the first or second decade of life as solitary flecks at the level of the Bowman layer. Over time, symmetric subepithelial reticular opacities develop in a honeycomb pattern, sparing the peripheral cornea (Fig&#160;7-7C). The opacities may progress to the deep stromal layers and the corneal periphery. Clinically distinguishing TBCD from RBCD is difficult, but noninvasive OCT and confocal microscopy may help differentiate these entities. Recurrent erosions in TBCD, which are less frequent and less severe than those in RBCD, cause ocular discomfort and pain. Vision decreases secondary to increased corneal opacification.</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">management</span> Management is similar to the approach used in RBCD.</p>
			<p class="reference-first">Kobayashi A, Sugiyama K. In vivo laser confocal microscopy findings for Bowman’s layer dystrophies (Thiel-Behnke and Reis-&#173;Bücklers corneal dystrophies). <span class="italic">Ophthalmology.</span> 2007;<br />114(1):69–75.</p>
			<p class="reference-mid">Küchle M, Green WR, Völcker HE, Barraquer J. Reevaluation of corneal dystrophies of Bowman’s layer and the anterior stroma (Reis-&#173;Bücklers and Thiel-&#173;Behnke types): a light and electron microscopic study of eight corneas and a review of the literature. <span class="italic">Cornea.</span> 1995;14(4):333–354.</p>
			<p class="reference-last--no-space-">Weiss JS, Møller HU, Aldave AJ, et al. IC3D classification of corneal dystrophies—edition&#160;2. <span class="italic">Cornea.</span> 2015;34(2):117–159.</p>
			<p class="h3 ParaOverride-5">Lattice corneal dystrophy type 1 (classic) (LCD1) and variants</p>
			<p class="h4-text ParaOverride-10"><span class="h4-head">Alternative names</span> Biber-Haab-Dimmer</p>
			<p class="h4-text ParaOverride-10"><span class="h4-head">Inheritance</span> AD</p>
			<p class="h4-text ParaOverride-10"><span class="h4-head">Category</span> 1</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">pathology</span> Light microscopy of classic lattice dystrophy shows arborizing amyloid deposits concentrated most heavily in the anterior stroma. Amyloid may also accumulate in the subepithelial area, giving rise to poor epithelial–stromal adhesion. Epithelial atrophy and disruption, with degeneration of basal epithelial cells, and focal thinning or absence of the Bowman layer increase progressively with age. An eosinophilic layer develops between the epithelial basement membrane and Bowman layer, with stromal deposition of the amyloid substance distorting the corneal lamellar architecture. Amyloid stains rose to orange-red with Congo red dye and metachromatically with crystal violet dye (<span class="xref-table">Table&#160;7-4</span>). It exhibits dichroism (shift from red-orange to apple green in response to a single rotating polarizing filter) and birefringence. (See BCSC Section&#160;4, <span class="italic">Ophthalmic Pathology and Intraocular Tumors,</span> Chapter&#160;6, for a discussion on birefringence [property of amyloid to change the axis of light polarization]). Electron microscopy reveals extracellular masses of fine 8–10-µm fibrils that are electron dense and randomly aligned. In vivo confocal microscopy reveals characteristic linear images that should be differentiated from those seen in infection with fungal hyphae (<span class="xref-figure">Fig&#160;7-8</span>). Corneal deposits caused by monoclonal gammopathy may resemble lattice lines.</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">clinical presentation</span> Lattice dystrophy is relatively common and is characterized by refractile branching lines in the corneal stroma. The spectrum of corneal changes is broad, and the classic branching lattice lines may not be present in all cases. Subtle refractile lines, central and subepithelial ovoid white dots, and diffuse anterior stromal haze appear early in life and, in a corneal graft, these may be the first signs of recurrence. The typical branching refractile lines, so-called lattice lines, develop as the condition progresses and are best seen against a red reflex or with indirect illumination (<span class="xref-figure">Fig&#160;7-9</span>). These lines start centrally and superficially and spread centrifugally, becoming deeper. The stroma can take on a “ground-glass” appearance, but the peripheral cornea typically remains clear. Epithelial erosions recur often and may occur as early as the first decade of life. Stromal haze and epithelial surface irregularity may decrease vision, typically in the fourth decade. Familial amyloidosis with lattice corneal changes (formerly lattice corneal dystrophy type&#160;2) is no longer considered a dystrophy (see Chapter&#160;8). Variant lattice dystrophy type&#160;IIIA is associated with severe erosions occurring later in life. Thick, ropy lattice lines and heavy amyloid deposits are seen (<span class="xref-figure">Fig&#160;7-10</span>). The findings in lattice dystrophy type&#160;IV occur more posteriorly than those in type&#160;IIIA and therefore type&#160;IV is less likely to be associated with erosions.</p>
			<p class="h5-text"><span class="h5-head">management</span> Recurrent erosions are managed with therapeutic contact lenses, superficial keratectomy, or PTK. Severe cases of lattice dystrophy with vision loss are treated with deep anterior lamellar keratoplasty (DALK) or PK. Recurrence of this dystrophy in the corneal graft is common.</p>
			<p class="reference-first ParaOverride-14">Aldave AJ, Vo RC, de Sousa LB, Mannis MJ. The stromal dystrophies. In: Mannis MJ, Holland EJ, eds. <span class="italic">Cornea.</span> Vol&#160;1. 4th&#160;ed. Philadelphia: Elsevier; 2017:781–799.</p>
			<p class="reference-mid">Pradhan MA, Henderson RA, Patel D, McGhee CN, Vincent AL. Heavy chain amyloidosis in TGFBI-&#173;negative and Gelsolin-&#173;negative atypical lattice corneal dystrophy. <span class="italic">Cornea.</span> 2011;<br />30(10):1163–1166.</p>
			<p class="reference-last--no-space-">Stock EL, Feder RS, O’Grady RB, Sugar J, Roth SI. Lattice corneal dystrophy type&#160;IIIA: clinical and histopathologic correlations. <span class="italic">Arch Ophthalmol.</span> 1991;109(3):354–358.</p>
			<p class="h3 ParaOverride-4">Granular corneal dystrophy type 1 (classic) (GCD1)</p>
			<p class="body-text--no-indent-">See Table&#160;7-4 for information on the histologic identification of granular corneal dystrophy.</p>
			<p class="h4-text ParaOverride-10"><span class="h4-head">Alternative names</span> Groenouw corneal dystrophy type I</p>
			<p class="h4-text ParaOverride-10"><span class="h4-head">Inheritance</span> AD</p>
			<p class="h4-text ParaOverride-10"><span class="h4-head">Category</span> 1</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">pathology</span> Microscopically, the granular material is hyaline, and it stains bright red with Masson trichrome stain. An electron-&#173;dense material made up of rod-shaped bodies immersed in an amorphous matrix is seen on electron microscopy. Histochemically, the deposits are noncollagenous protein that may derive from the corneal epithelium and/or keratocytes. Hyperreflective opacities are seen on confocal microscopy. Although the exact cause is unknown, a mutation different from that in RBCD, LCD1, and granular corneal dystrophy type&#160;2 (GCD2; granular-&#173;lattice) has been identified in the <span class="italic">TGFBI</span> gene on 5q31, which is responsible for the formation of keratoepithelin.</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">clinical presentation</span> Onset occurs early in life with crumblike opacities in the superficial cornea. With direct illumination, the opacities appear white; however, indirect illumination reveals small translucent dots with vacuoles and a glassy splinter or “crushed bread crumb” appearance. The lesions are separated by clear spaces early in the disease process but later become more confluent. The lesions do not extend to the limbus but can extend anteriorly through focal breaks in the Bowman layer (<span class="xref-figure">Fig&#160;7-11</span>). The dystrophy is slowly progressive, with most patients maintaining good vision and visual acuity, and only rarely dropping to 20/200 after age 50&#160;years. Patients report glare and photophobia. Recurrent erosions occur and vision decreases as the opacities become more confluent.</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">management</span> Early in the disease process, no treatment is needed. Recurrent erosions may be treated with therapeutic contact lenses and superficial keratectomy. PTK may work transiently. When vision is affected, DALK or PK has a good prognosis. The disease may recur in the graft after several years, presenting as fine subepithelial opacities anteriorly and peripherally in contrast to the original presentation. Laser refractive surgery should be avoided in patients with granular dystrophy because of the risk of haze.</p>
			<p class="h3 ParaOverride-15">Granular corneal dystrophy type 2 (GCD2)</p>
			<p class="h4-text ParaOverride-10"><span class="h4-head">Alternative names</span> Avellino corneal dystrophy</p>
			<p class="h4-text ParaOverride-10"><span class="h4-head">Inheritance</span> AD</p>
			<p class="h4-text ParaOverride-10"><span class="h4-head">Category</span> 1</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">pathology</span> Pathologically, both the hyaline deposits typical of granular dystrophy and the amyloid deposits typical of lattice dystrophy are seen. These lesions extend from the basal epithelium to the deep corneal stroma. Individual opacities stain with the Masson trichrome or Congo red stain. The deposits appear as rod-shaped bodies on electron microscopy; randomly aligned fibrils of amyloid are also seen. Findings on confocal microscopy are a combination of those seen in GCD1 and LCD.</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">clinical presentation</span> Affected patients have a granular dystrophy both histologically and clinically, with shorter, whiter lattice lesions in addition to the granular lesions. Clinical findings in GCD2 differ from those in GCD1. Stellate-&#173;shaped, snowflake-&#173;like, and icicle-&#173;like opacities appear between the superficial stroma and midstroma (<span class="xref-figure">Fig&#160;7-12</span>). Lattice lines are also seen deeper than the snowflake opacities. Older patients have anterior stromal haze between deposits, which reduces vision. Pain may occur with mild corneal erosions.</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">management</span> Lamellar or penetrating keratoplasty may be useful, depending on the depth of the deposits. PTK may be considered as an alternative to reduce surface irregularity and increase corneal clarity. Laser in situ keratomileusis (LASIK) and PRK are contraindicated.</p>
			<p class="reference-first ParaOverride-10">Aldave AJ, Vo RC, de Sousa LB, Mannis MJ. The stromal dystrophies. In: Mannis MJ, Holland EJ, eds. <span class="italic">Cornea.</span> Vol&#160;1. 4th&#160;ed. Philadelphia: Elsevier; 2017:781–799.</p>
			<p class="reference-mid">Holland EJ, Daya SM, Stone EM, et al. Avellino corneal dystrophy. Clinical manifestations and natural history. <span class="italic">Ophthalmology.</span> 1992;99(10):1564–1568.</p>
			<p class="reference-mid">Kim TI, Hong JP, Ha BJ, Stulting RD, Kim EK. Determination of treatment strategies for granular corneal dystrophy type&#160;2 using Fourier-&#173;domain optical coherence tomography. <span class="italic">Br&#160;J Ophthalmol.</span> 2010;94(3):341–345.</p>
			<p class="reference-last--no-space-">Weiss JS, Møller HU, Aldave AJ, et al. IC3D classification of corneal dystrophies—edition&#160;2. <span class="italic">Cornea.</span> 2015;34(2):117–159.</p>
			<p class="h2 ParaOverride-15">Stromal Dystrophies</p>
			<p class="h3-h2">Macular corneal dystrophy (MCD)</p>
			<p class="h4-text ParaOverride-9"><span class="h4-head">Alternative names</span> Groenouw corneal dystrophy type II</p>
			<p class="h4-text ParaOverride-9"><span class="h4-head">Inheritance</span> AR</p>
			<p class="h4-text ParaOverride-9"><span class="h4-head">Category</span> 1</p>
			<p class="h5-text ParaOverride-9"><span class="h5-head">pathology</span> The deposits in macular dystrophy are glycosaminoglycans (GAGs), or acid mucopolysaccharides, and they stain with colloidal iron and alcian blue (see Table&#160;7-4). They accumulate in the endoplasmic reticulum and not in lysosomal vacuoles, as seen in systemic mucopolysaccharidoses. Electron microscopy reveals keratocytes and endothelial cells that stain positive for GAGs, as well as extracellular clumps of fibrogranular material that also stains for GAGs. On confocal microscopy, blurred accumulations of light-&#173;reflective material are seen in the anterior corneal stroma.</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">clinical presentation</span> Macular dystrophy occurs less frequently than the stromal dystrophies associated with mutations in the <span class="italic">TGFBI</span> gene. Unlike most corneal dystrophies, it has an autosomal recessive inheritance, involves the entire corneal stroma and periphery, and may involve the corneal endothelium. The corneas are clear at birth and begin to cloud between 3 and 9&#160;years of age.</p>
			<p class="body-text">Patients with macular dystrophy initially show superficial, irregular, whitish, flecklike opacities that evolve into focal, gray-white, superficial stromal opacities with intervening haze. Unlike in GCD, the lesions progress to involve all layers of the cornea and extend to the corneal periphery. The opacities tend to be more superficial centrally and more posterior peripherally. Macular spots have indefinite edges (<span class="xref-figure">Fig&#160;7-13</span>). Involvement of the Descemet membrane and endothelium is indicated by the presence of guttate excrescences, but corneal edema does not occur. Dystrophic opacities in the periphery may also appear similar to keratic precipitates. Epithelial erosions rarely develop, but a severe decrease in vision typically occurs between 10 and 30&#160;years of age. Hypoesthesia has been noted. Central corneal thinning is common and may appear similar to long-&#173;standing interstitial keratitis (IK), but the ghost vessels and thickened Descemet membrane seen in IK help differentiate the conditions.</p>
			<p class="body-text">There are 3&#160;variants of macular dystrophy, and they are distinguished based on biochemical differences. In type&#160;I, the most prevalent form of macular dystrophy, antigenic keratan sulfate (AgKS) is lacking in the cornea, serum, and cartilage. In affected patients, there is normal synthesis of dermatan sulfate proteoglycan. Errors occur in the synthesis of keratan sulfate and in the activity of specific sulfotransferases involved in the sulfation of the keratan sulfate lactose aminoglycan side chain. In type&#160;IA, keratocytes show AgKS reactivity, but the extracellular material does not. There is no AgKS in the serum. In macular dystrophy type&#160;II, all of the abnormal deposits react positively with AgKS, and the serum has normal or lower levels of AgKS.</p>
			<p class="body-text">An enzyme-linked immunosorbent assay (ELISA) measures sulfated keratan sulfate. This test can help in the diagnosis of macular dystrophy, even in preclinical forms and carriers.</p>
			<p class="h5-text"><span class="h5-head">management</span> Recurrent erosions should be treated, and photophobia may be reduced with tinted contact lenses. PTK may be used for symptomatic anterior macular dystrophy. Definitive treatment requires PK or DALK, and recurrences are uncommon.</p>
			<p class="reference-first ParaOverride-12">Aldave AJ, Vo RC, de Sousa LB, Mannis MJ. The stromal dystrophies. In: Mannis MJ, <br />Holland EJ, eds. <span class="italic">Cornea.</span> Vol&#160;1. 4th&#160;ed. Philadelphia: Elsevier; 2017:781–799.</p>
			<p class="reference-last--no-space-">Weiss JS, Møller HU, Aldave AJ, et al. IC3D classification of corneal dystrophies—<br />edition&#160;2. <span class="italic">Cornea.</span> 2015;34(2):117–159.</p>
			<p class="h3 ParaOverride-16">Schnyder corneal dystrophy (SCD)</p>
			<p class="h4-text ParaOverride-10"><span class="h4-head">Inheritance</span> AD</p>
			<p class="h4-text ParaOverride-10"><span class="h4-head">Category</span> 1</p>
			<p class="h5-text"><span class="h5-head">pathology</span> This condition is thought to be a local disorder of corneal lipid metabolism. Pathologically, the opacities are accumulations of unesterified and esterified cholesterol and phospholipids. Lipids stain with oil red&#160;O and Sudan black&#160;B (see Table&#160;7-4). In the normal process of embedding tissue in paraffin, cholesterol and other fatty substances are dissolved; therefore, fresh tissue should be submitted to the pathologist for special lipid stains. Electron microscopy shows abnormal accumulation of lipid and dissolved cholesterol in the corneal epithelium, in the Bowman layer, and throughout the stroma. Confocal microscopy reveals disruption of the basal epithelial/subepithelial nerve plexus, with highly reflective intracellular and extracellular deposits.</p>
			<p class="h5-text"><span class="h5-head">clinical presentation</span> Schnyder corneal dystrophy is a rare, slowly progressive stromal dystrophy that may become apparent as early as in the first year of life. The diagnosis is usually made by the second or third decade of life, although it may be further delayed in patients who have the crystalline form of the disease. Central subepithelial crystals are seen in only 50% of patients and do not involve the epithelium. For this reason, the name Schnyder crystalline dystrophy has been replaced. Vision and corneal sensation decrease with age. Glare increases because of progressive corneal haze.</p>
			<p class="body-text">Changes are progressive and predictable by age, beginning with central corneal opacification:</p>
			<p class="numbered-list-first ParaOverride-12">&#9;1.&#9;ring or disclike central corneal opacification (can affect the entire corneal stromal thickness) ± subepithelial crystals (<span class="xref-figure">Fig&#160;7-14A</span>); individuals younger than 23&#160;years</p>
			<p class="numbered-list-mid">&#9;2.&#9;dense corneal arcus lipoides (Fig&#160;7-14B); third decade of life</p>
			<p class="numbered-list-mid">&#9;3.&#9;midperipheral corneal opacification (affects entire corneal stromal thickness); fourth decade</p>
			<p class="numbered-list-mid">&#9;4.&#9;corneal sensation that decreases with age</p>
			<p class="numbered-list-last">&#9;5.&#9;abnormal lipid profile</p>
			<p class="h5-text"><span class="h5-head">management</span> Schnyder corneal dystrophy disproportionately reduces photopic vision (despite maintenance of excellent scotopic vision); thus, most SCD patients older than 50&#160;years require corneal transplant surgery. The dystrophy can recur after PK or DALK. PTK has been used to treat decreased vision from subepithelial crystals, but it does not reduce panstromal haze. A fasting lipid profile should be done to detect possible hyperlipoproteinemia or hyperlipidemia. Patients with abnormal serum lipid levels are managed with dietary changes and/or medication, but the progression of the corneal dystrophy is unaltered. Unaffected family members may also have an abnormal lipid profile.</p>
			<p class="reference-single--no-space-">Weiss JS. Visual morbidity in thirty-&#173;four families with Schnyder crystalline corneal dystrophy (an American Ophthalmological Society thesis). <span class="italic">Trans Am Ophthalmol Soc.</span> 2007;105:616–648.</p>
			<p class="h3 ParaOverride-16">Congenital stromal corneal dystrophy (CSCD)</p>
			<p class="h4-text"><span class="h4-head">Inheritance</span> AD</p>
			<p class="h4-text"><span class="h4-head">Category</span> 1</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">pathology</span> The stromal lamellae are separated from each other in a regular manner, sometimes with areas of amorphous deposition. On electron microscopy, the collagen fibril diameter is approximately half the normal size in all lamellae. Abnormal lamellar layers consisting of thin filaments arranged in an electron-&#173;lucent ground substance separate the lamellae of normal appearance. The keratocytes and endothelium are normal. The absence of the anterior banded zone of Descemet membrane has been reported. The epithelial cells are normal on confocal microscopy. Stromal evaluation is not possible because of increased reflectivity.</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">clinical presentation</span> Congenital diffuse, bilateral corneal clouding with flakelike, whitish opacities is found throughout the stroma (<span class="xref-figure">Fig&#160;7-15</span>). The corneas are thickened. The course is nonprogressive or slowly progressive, with moderate to severe vision loss.</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">management</span> Penetrating keratoplasty is recommended in advanced cases.</p>
			<p class="reference-single--no-space- ParaOverride-12">Bredrup C, Knappskog PM, Majewski J, Rødahl E, Boman H. Congenital stromal dystrophy of the cornea caused by a mutation in the decorin gene. <span class="italic">Invest Ophthalmol Vis Sci.</span> 2005;<br />46(2):420–426.</p>
			<p class="h3 ParaOverride-5">Fleck corneal dystrophy (FCD)</p>
			<p class="h4-text"><span class="h4-head">Alternative names</span> François-Neetens speckled corneal dystrophy</p>
			<p class="h4-text"><span class="h4-head">Inheritance</span> AD</p>
			<p class="h4-text"><span class="h4-head">Category</span> 1</p>
			<p class="h5-text"><span class="h5-head">pathology</span> Affected keratocytes are vacuolated and contain 2&#160;abnormal substances: excess glycosaminoglycan, which stains with alcian blue and colloidal iron; and lipids, which stain with Sudan black&#160;B and oil red&#160;O. Transmission electron microscopy shows membrane-&#173;based inclusions with delicate granular material. Confocal microscopy shows an accumulation of pathologic material in stromal cells and inclusions in the basal nerves.</p>
			<p class="h5-text"><span class="h5-head">clinical presentation</span> Fleck corneal dystrophy is a nonprogressive condition that may be congenital or may present early in the first decade of life. Discrete, flat, gray-white, dandrufflike (sometimes ring-shaped) opacities appear throughout the corneal stroma to its periphery (<span class="xref-figure">Fig&#160;7-16</span>). The epithelium, Bowman layer, Descemet membrane, and endothelium are not involved. Fleck dystrophy may be unilateral or bilateral but asymmetric. Symptoms are minimal, and vision is usually not reduced. Fleck dystrophy may be associated with decreased corneal sensation, limbal dermoid, keratoconus, central cloudy dystrophy, punctate cortical lens changes, pseudoxanthoma elasticum, or atopy.</p>
			<p class="h5-text"><span class="h5-head">management</span> None is required.</p>
			<p class="reference-single--no-space- ParaOverride-12">Purcell JJ Jr, Krachmer JH, Weingeist TA. Fleck corneal dystrophy. <span class="italic">Arch Ophthalmol.</span> 1977;<br />95(3):440–444.</p>
			<p class="h3 ParaOverride-5">Posterior amorphous corneal dystrophy (PACD)</p>
			<p class="h4-text ParaOverride-10"><span class="h4-head">Inheritance</span> AD</p>
			<p class="h4-text ParaOverride-10"><span class="h4-head">Category</span> 3; may be a mesodermal dysgenesis rather than a corneal dystrophy</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">pathology</span> Focal attenuation of corneal endothelial cells and irregular stromal architecture anterior to the Descemet membrane are seen on light microscopy. On electron microscopy, there is disorganization of the posterior stromal lamellae. A fibrillar layer interrupts the Descemet membrane. On confocal microscopy, there are microfolds and a hyperreflective layer in the posterior stroma.</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">clinical presentation</span> Posterior amorphous dystrophy presents in the first decade of life with a diffuse, sheetlike, gray-white opacity, usually in the posterior cornea (<span class="xref-figure">Fig&#160;7-17</span>). The condition is usually nonprogressive. The cornea is flat (&lt;41&#160;D) and thin (as thin as 380&#160;µm), and there is associated hyperopia. Cornea plana, a bilateral familial disease caused by a mutation in the <span class="italic">KERA</span> gene, also has marked flattening of the cornea and is also stationary. In PACD, the Descemet membrane and the corneal endothelium may be indented by opacities. Focal endothelial abnormalities, a prominent Schwalbe line, fine iris processes, pupillary remnant, iridocorneal adhesions, corectopia, pseudopolycoria, and anterior stromal tags have been noted. There is no associated glaucoma. Visual acuity is usually 20/40 or better.</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">management</span> Although usually no treatment is required, PK is sometimes performed.</p>
			<p class="reference-first ParaOverride-14">Dunn SP, Krachmer JH, Ching SS. New findings in posterior amorphous corneal dystrophy. <span class="italic">Arch Ophthalmol.</span> 1984;102(2):236–239.</p>
			<p class="reference-last--no-space-">Johnson AT, Folberg R, Vrabec MP, Florakis GJ, Stone EM, Krachmer JH. The pathology of posterior amorphous corneal dystrophy. <span class="italic">Ophthalmology.</span> 1990;97(1):104–109.</p>
			<p class="h3 ParaOverride-16">Pre-Descemet corneal dystrophy (PDCD)</p>
			<p class="h4-text ParaOverride-10"><span class="h4-head">Inheritance</span> No definite pattern of inheritance, although PDCD has been described in families through 2–4&#160;generations</p>
			<p class="h4-text ParaOverride-10"><span class="h4-head">Category</span> 1 (PDCD associated with X-linked ichthyosis), 4 (isolated PDCD)</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">pathology</span> Large keratocytes are seen in the posterior stroma, with vacuoles and intracytoplasmic inclusions containing lipidlike material. On electron microscopy, there are membrane-&#173;bound intracellular vacuoles containing electron-&#173;dense material suggestive of secondary lysosomes, and there are inclusions consistent with lipofuscin-&#173;like lipoprotein, suggesting a degenerative process.</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">clinical presentation</span> Onset is usually after 30&#160;years of age, but it has been reported in children as young as 3&#160;years old. Focal fine, polymorphic, gray opacities that may be central, annular, or diffuse are seen in the deep stroma just anterior to the Descemet membrane (<span class="xref-figure">Fig&#160;7-18</span>). The rest of the cornea is unaffected. Vision is normal. Similar opacities have been described in pseudoxanthoma elasticum, X-linked and recessive ichthyosis, keratoconus, posterior polymorphous corneal dystrophy, and EBMD.</p>
			<p class="h5-text ParaOverride-9"><span class="h5-head">management</span> None is indicated.</p>
			<p class="h2 ParaOverride-13">Endothelial Dystrophies</p>
			<p class="h3-h2">Fuchs endothelial corneal dystrophy (FECD)</p>
			<p class="h4-text ParaOverride-9"><span class="h4-head">Alternative names</span> Endothelial corneal dystrophy</p>
			<p class="h4-text ParaOverride-9"><span class="h4-head">Inheritance</span> Cases without known inheritance are most common; some cases with AD inheritance have been reported</p>
			<p class="h4-text ParaOverride-9"><span class="h4-head">Category</span> 1 (early-&#173;onset FECD); 2 (FECD with known genetic loci but gene not yet localized, although transcription factor&#160;4 [TCF4] may be implicated in these patients); 3 (FECD in patients with no known inheritance)</p>
			<p class="h5-text ParaOverride-9"><span class="h5-head">pathology</span> Microscopically, the endothelial cells are noted to be more varied in size (polymegethism) and more irregular in shape (pleomorphism) than normal and are disrupted by excrescences of collagen. Primary dysfunction of the endothelial cells manifests as increased corneal swelling and deposition of collagen and extracellular matrix in the Descemet membrane, which is thickened. There is a reduction in the number of Na<span class="superscript _idGenCharOverride-1">+</span>,K<span class="superscript _idGenCharOverride-1">+</span>-ATPase pump sites or in pump function. It is not clear whether the reduction in the posterior nonbanded zone and the increase in thickness of the abnormal posterior collagenous layer are primary effects of endothelial dysfunction or are secondary to chronic corneal edema.</p>
			<p class="h5-text ParaOverride-9"><span class="h5-head">clinical presentation</span> Findings vary with the severity of the disease. Cornea guttata is first evident centrally and then spreads toward the periphery (stage&#160;1). In some patients, cornea guttata develops, and the disease never progresses beyond this stage (<span class="xref-figure">Fig&#160;7-19</span>). Cornea guttae may become confluent and take on a “beaten metal” appearance. Cornea guttae in late-&#173;onset FECD are larger than those seen in early-&#173;onset FECD. Stage&#160;2 is characterized by endothelial decompensation and stromal edema (<span class="xref-figure">Fig&#160;7-20</span>). As the disease progresses, the Descemet membrane may become thickened, and stromal edema may worsen, causing epithelial bullae and bullous keratopathy (stage&#160;3). The central corneal thickness may approach 1&#160;mm (0.50–0.60&#160;mm is typically considered normal). Subepithelial fibrosis, scarring, and peripheral superficial vascularization secondary to chronic edema occur in end-stage disease (stage&#160;4).</p>
			<p class="body-text">Fuchs dystrophy usually presents in the fourth decade of life or later (except in the case of the early-&#173;onset variant, which may present as early as the first decade of life). Symptoms are rare before 50&#160;years of age and are related to the edema, which causes a decrease in vision, contrast sensitivity, and/or glare. Pain may result from ruptured bullae or microcystic edema. Symptoms are often worse upon awakening because of decreased surface evaporation during sleep. Painful episodes may subside once subepithelial fibrosis occurs.</p>
			<p class="h5-text ParaOverride-9"><span class="h5-head">management</span> Initial treatment is aimed at reducing corneal edema, which typically begins in the morning, and relieving pain. Use of sodium chloride drops and ointment (5%), as well as measures taken to lower intraocular pressure (IOP), may temporarily help the edema. A bandage contact lens may be useful in treating ruptured bullae. In advanced cases, anterior stromal puncture, placement of amniotic membrane, or a conjunctival flap may be considered to relieve pain, but restoration of vision requires a corneal transplant. In the past, full-&#173;thickness (penetrating) keratoplasty was the standard procedure, but this has been largely replaced by endothelial keratoplasty (EK), as the latter targets the pathologic endothelial cells. In one recent case series, removal of a relatively small area of abnormal Descemet membrane and endothelium (descemetorhexis) resulted in mitosis of normal endothelial cells or their from the periphery, leading to resolution of the edema and improvement in vision. In the future, more traditional keratoplasty may be replaced with descemetorhexis combined with topical and/or intracameral Rho kinase (ROCK) inhibitor to stimulate endothelial proliferation. Another future treatment may be injection of the patient’s own cultured endothelial cells. In advanced cases where there has been anterior corneal scarring, a full-&#173;thickness procedure may still be indicated. The prognosis for graft survival is good, especially if the procedure is done before vascularization occurs. See Chapter&#160;15 for detailed discussion of corneal transplantation as well as new therapeutic modalities.</p>
			<p class="h5-text"><span class="h5-head">comment</span> Specular microscopy may be helpful in the initial evaluation of Fuchs dystrophy and in following the clinical course for loss of corneal endothelial cells; however, it is not necessary in the presence of diffuse confluent guttae. Corneal pachymetry may indicate relative corneal endothelial function, and the readings may change with progression of the disease; pachymetry can also be helpful in determining the relative safety of cataract or other intraocular surgery in a patient with FECD. Endothelial cell counts less than 1000/mm<span class="superscript CharOverride-1">2</span>, morning increase in corneal thickness, or the presence of epithelial edema suggests that the cornea may decompensate following intraocular surgery (see Chapter&#160;2); thus, appropriate precautionary measures should be taken. See BCSC Section&#160;11, <span class="italic">Lens and Cataract.</span></p>
			<p class="reference-first ParaOverride-14">Baratz KH, Tosakulwong N, Ryu E, et al. E2-2 protein and Fuchs’s corneal dystrophy. <span class="italic">N&#160;Engl J&#160;Med.</span> 2010;363(11):1016–1024.</p>
			<p class="reference-mid">Borkar DS, Veldman P, Colby KA. Treatment of Fuchs endothelial dystrophy by Descemet stripping without endothelial keratoplasty. <span class="italic">Cornea.</span> 2016;35(10):1267–1273.</p>
			<p class="reference-mid">Gottsch JD, Sundin OH, Liu SH, et al. Inheritance of a novel <span class="italic">COL8A2</span> mutation defines a distinct early-&#173;onset subtype of Fuchs corneal dystrophy. <span class="italic">Invest Ophthalmol Vis Sci.</span> 2005;<br />46(6):1934–1939.</p>
			<p class="reference-last--no-space-">Li YJ, Minear MA, Rimmler J, et al. Replication of <span class="italic">TCF4</span> through association and linkage studies in late-&#173;onset Fuchs endothelial corneal dystrophy. <span class="italic">PLoS One</span> [serial online]. 2011;<br />6(4):e18044. Available at www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0018044. Accessed January 30, 2017.</p>
			<p class="h3 ParaOverride-16">Posterior polymorphous corneal dystrophy (PPCD)</p>
			<p class="h4-text ParaOverride-10"><span class="h4-head">Alternative names</span> Posterior polymorphous dystrophy (PPMD), Schlichting dystrophy</p>
			<p class="h4-text ParaOverride-10"><span class="h4-head">Inheritance</span> AD (isolated unilateral cases with similar phenotype but no heredity reported)</p>
			<p class="h4-text ParaOverride-10"><span class="h4-head">Category</span> 2 (PPCD1); 1 (PPCD2, PPCD3)</p>
			<p class="h5-text"><span class="h5-head">pathology</span> The most distinctive microscopic finding is the appearance of abnormal, multilayered corneal endothelial cells that look and behave like epithelial cells or fibroblasts. These endothelial cells have the following features or characteristics:</p>
			<ul>
				<li class="bullet-list-first ParaOverride-6">microvilli</li>
				<li class="bullet-list-mid">positive immunohistochemical staining for keratin</li>
				<li class="bullet-list-mid">rapid and easy growth in cell culture</li>
				<li class="bullet-list-mid">intercellular desmosomes</li>
				<li class="bullet-list-last ParaOverride-8">proliferative tendencies</li>
			</ul>
			<p class="body-text--no-indent-">A diffuse abnormality of Descemet membrane is common, including thickening of the posterior nonbanded layer, a multilaminated appearance, and polymorphous alterations. Similar changes that are not limited to the cornea are seen in iridocorneal endothelial (ICE) syndrome (see Chapter&#160;6). ICE, however, is sporadic and almost always unilateral. Specular microscopy may show typical vesicles and bands, in contrast to the involved cells in ICE syndrome, which appear as dark areas with central highlights and light peripheral borders. Opinion is divided on the value of relying on specular microscopy alone in making the diagnosis. Confocal microscopy reveals vesicular lesions and railroad track, bandlike dark areas with irregular edges.</p>
			<p class="h5-text"><span class="h5-head">clinical presentation</span> Careful examination of the posterior corneal surface will show any or all of the following:</p>
			<ul>
				<li class="bullet-list-first ParaOverride-6">isolated grouped endothelial vesicles (<span class="xref-figure">Fig&#160;7-21A</span>)</li>
				<li class="bullet-list-mid">geographic-shaped, discrete, gray lesions</li>
				<li class="bullet-list-last ParaOverride-8">broad endothelial bands with scalloped edges (Fig&#160;7-21B)</li>
			</ul>
			<p class="body-text--no-indent-">Various degrees of stromal edema, corectopia, and broad iridocorneal adhesions may also be seen (<span class="xref-figure">Fig&#160;7-22</span>). Fine, glasslike iridocorneal adhesions may be seen on gonioscopy. Both angle-&#173;closure and open-&#173;angle glaucoma can occur, and 14% of patients with PPCD have elevated IOP.</p>
			<p class="h5-text"><span class="h5-head">management</span> Most patients are asymptomatic. Mild corneal edema may be managed in the same manner as early Fuchs dystrophy. Anterior stromal puncture can be used to induce focal subepithelial fibrosis in cases of localized swelling. With more severe disease, keratoplasty may be required and, if present, glaucoma must be managed. If peripheral anterior synechiae, glaucoma, or both are present preoperatively, the prognosis for successful corneal transplant is reduced. PPCD may recur in the graft. In cases with limited stromal opacification, EK is the preferred approach for targeting the abnormal endothelial cells.</p>
			<p class="reference-single--no-space-">Weinstein JE, Weiss JS. Descemet membrane and endothelial dystrophies. In: Mannis MJ, Holland EJ, eds. <span class="italic">Cornea.</span> Vol&#160;1. 4th&#160;ed. Philadelphia: Elsevier; 2017:800–817.</p>
			<p class="h3 ParaOverride-16">Congenital hereditary endothelial dystrophy (CHED)</p>
			<p class="h4-text"><span class="h4-head">Alternative names</span> Formerly divided into 2&#160;forms, CHED1 (AD) and CHED2 (AR); however, a careful review of the findings from reported families suggests that CHED&#160;1 is actually indistinct from PPCD1.</p>
			<p class="h4-text"><span class="h4-head">Inheritance</span> AR</p>
			<p class="h4-text"><span class="h4-head">Category</span> 1</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">pathology</span> There is diffuse thickening and lamination of the Descemet membrane, with sparse atrophic corneal endothelial cells. On electron microscopy, multiple layers of basement membrane–like material are seen on the posterior part of the Descemet membrane, along with degeneration of the endothelial cells, which show many vacuoles. Stromal thickening with severe disorganization and disruption of the lamellar pattern is evident.</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">clinical presentation</span> This dystrophy is a congenital, usually nonprogressive condition with asymmetric corneal clouding and edema that ranges from a diffuse haze to a ground-glass appearance; focal gray spots are occasionally seen. Thickening of the cornea (2–3&#160;times normal) occurs (<span class="xref-figure">Fig&#160;7-23</span>), with rare subepithelial band keratopathy and IOP elevation. Blurred vision and nystagmus occur with minimal to no tearing or photophobia.</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">management</span> Due to marked corneal edema present in more severe cases, corneal transplant (PK or EK) is required.</p>
			<p class="reference-single--no-space- ParaOverride-10">Weinstein JE, Weiss JS. Descemet membrane and endothelial dystrophies In: Mannis MJ, Holland EJ, eds. <span class="italic">Cornea.</span> Vol&#160;1. 4th&#160;ed. Philadelphia: Elsevier; 2017:800–817.</p>
			</div>
			<p class="h1">Ectatic Disorders</p>
		    <div id="Chapt7_Top3">
			<p class="h2-h1">Keratoconus</p>
			<p class="body-text--no-indent-">Keratoconus is a common disorder (incidence of about 1 per 2000) in which the central or paracentral cornea undergoes progressive thinning and protrusion, resulting in a cone-shaped cornea (<span class="xref-figure">Fig&#160;7-24</span>; see also Fig&#160;7-34). A hereditary pattern is not prominent or predictable, but positive family histories have been reported in 6%–8% of cases. Multiple chromosomal loci for keratoconus have been reported, but the identification of specific genes remains elusive. Clinically unaffected first-&#173;degree relatives have a higher chance of showing subclinical topographic abnormalities associated with keratoconus than does the general population. The prevalence of keratoconus in first-&#173;degree relatives has been shown to be 3.34%. There is a slight female preponderance, and the incidence is higher in South Asia and the Middle East. Genetic predisposition and environmental risk factors such as eye rubbing, inflammation, atopy, hard contact lens wear, and oxidative stress all play a role in the onset and progression of keratoconus.</p>
			<p class="body-text">The onset of keratoconus is during puberty, and progression typically occurs until 40&#160;years of age, although it can occur at any time. The presence of hyperelastic joints may be as high as 50% in these patients. Keratoconus can be associated with ocular diseases such as vernal keratoconjunctivitis, Leber tapetoretinal degeneration, retinitis pigmentosa, and floppy eyelids. It can also be associated with systemic diseases, including atopic disease, Down syndrome, Ehlers-&#173;Danlos syndrome, osteogenesis imperfecta, sleep apnea, and mitral valve prolapse.</p>
			<p class="reference-first ParaOverride-12">Feder RS, Neems LC. Noninflammatory ectatic disorders. In: Mannis MJ, Holland EJ, eds. <span class="italic">Cornea.</span> Vol&#160;1. 4th&#160;ed. Philadelphia: Elsevier; 2017:820–843.</p>
			<p class="reference-mid">Kiliç A, Colin J. Advances in the surgical treatment of keratoconus. <span class="italic">Focal Points: Clinical Modules for Ophthalmologists.</span> San Francisco: American Academy of Ophthalmology; 2012, module&#160;2.</p>
			<p class="reference-mid">McMonnies CW. Abnormal rubbing and keratectasia. <span class="italic">Eye Contact Lens.</span> 2007;33(6&#160;Pt&#160;1):<br />265–271.</p>
			<p class="reference-mid">Saidel MA, Paik JY, Garcia C, Russo P, Cao D, Bouchard C. Prevalence of sleep apnea syndrome and high-risk characteristics among keratoconus patients. <span class="italic">Cornea.</span> 2012;31(6):<br />600–603.</p>
			<p class="reference-last--no-space-">Wang Y, Rabinowitz YS, Rotter JI, Yang H. Genetic epidemiological study of keratoconus: evidence for major gene determination. <span class="italic">Am&#160;J Med Genet.</span> 2000;93(5):403–409.</p>
			<p class="h5-text"><span class="h5-head">pathology</span> Histologically, keratoconus shows the following:</p>
			<ul>
				<li class="bullet-list-first">iron deposition in the basal epithelium at the base of the cone</li>
				<li class="bullet-list-mid">fragmentation or breaks of the Bowman layer</li>
				<li class="bullet-list-mid">thinning of the corneal stroma and overlying epithelium</li>
				<li class="bullet-list-mid">folds or breaks in the Descemet membrane</li>
				<li class="bullet-list-last ParaOverride-7">variable amounts of apical scarring</li>
			</ul>
			<p class="h5-text"><span class="h5-head">clinical presentation</span> Nearly all cases are bilateral, but asymmetry is common. Early biomicroscopic and histologic findings include breaks in the Bowman layer followed by fibrous growth through the break, leading to reticular scarring (<span class="xref-figure">Fig&#160;7-25</span>). As progression occurs, the apical thinning of the central cornea worsens, as does the degree of irregular astigmatism. There is generally no associated keratitis or corneal neovascularization.</p>
			<p class="body-text">Scissoring of the red reflex on retinoscopy is commonly associated with irregular astigmatism and is an early sign of keratoconus. <span class="italic">Rizzutti sign,</span> a focusing of the light within the nasal limbus when a penlight is shone from the temporal side, is another early but nonspecific finding. <span class="italic">Munson sign,</span> an inferior deviation of the lower eyelid contour on downgaze (<span class="xref-figure">Fig&#160;7-26</span>), is also nonspecific and is a late sign. Iron deposition within the basal epithelium at the base of the cone forms a <span class="italic">Fleischer ring</span> (<span class="xref-figure">Fig&#160;7-27</span>), best seen with the slit lamp using a broad, oblique beam and the cobalt-&#173;blue filter. The line becomes narrower and increasingly well defined as the disease progresses. Fine, parallel stress lines, <span class="italic">Vogt striae,</span> can be observed in the posterior stroma at the apex of the cone and may clear with application of external pressure (<span class="xref-figure">Fig&#160;7-28</span>).</p>
			<p class="body-text">Spontaneous perforation in keratoconus is extremely rare. However, a tear can occur in the Descemet membrane, usually late in the disease course, resulting in the sudden development of corneal edema, or <span class="italic">acute hydrops</span> (<span class="xref-figure">Fig&#160;7-29</span>). Allergy and eye rubbing are risk factors for the development of hydrops, which is more common in patients with Down syndrome. The break in the posterior cornea usually heals spontaneously within 3&#160;months; the corneal edema then disappears, but posterior stromal scarring occurs. Some patients experience improved vision following the resolution of hydrops because of apical flattening. The improved vision will depend on the extent and location of the scar. Occasionally, stromal clefts can be seen in association with hydrops. Even large clefts usually close, but corneal neovascularization can develop.</p>
			<p class="h5-text ParaOverride-10"><span class="h5-head">evaluation</span> Keratometry can be used to detect keratoconus even at an early stage. Irregular astigmatism, indicated by the inability to superimpose the mires, is commonly seen. Inferior steepening, an early finding in keratoconus, can be detected by comparing measurements obtained with the patient in primary gaze to those in upgaze. Corneal topography and corneal tomography (<span class="xref-figure">Fig&#160;7-30</span>) have become indispensable in the management of keratoconus and are used by clinicians in several ways, such as detecting early keratoconus, following its progression, fitting contact lenses, and managing the postoperative patient. Important power map findings include superior flattening, inferior steepening, increase in I–S ratio (inferior to superior power), and significant skewing of the radial axes of the bow tie, in contrast to the normal symmetric bow-tie pattern of regular astigmatism. Findings obtained via slit-&#173;scanning devices, Scheimpflug imaging, or anterior segment OCT include decentered islands of elevation anteriorly and/or posteriorly. The elevation map is developed in reference to a computer-&#173;generated best-fit sphere.</p>
			<p class="body-text">These devices can also identify abnormal corneal thinning and/or decentration of the thinnest cornea, which is particularly significant when it is coincident with an island of elevation. Scheimpflug imaging and OCT have largely supplanted ultrasonic pachymetry. Accurate measurement of corneal thickness and elevation has been the cornerstone of recent advances in keratoconus detection programs. Examples of other advances are the various indices and graphic representations of both the change in thickness from thinnest cornea to limbus (more dramatic in keratoconus) and the impact of calculations of the best-fit sphere when the thinnest cornea is included or eliminated from the calculation. Serial evaluations over time are necessary to determine whether the changes noted are unlikely to progress (forme fruste keratoconus) or whether subclinical or suspected keratoconus is progressing and likely to become symptomatic. Corneal ectasia can also occur in association with ablative keratorefractive surgery (eg, LASIK or PRK). Risk factors for ectasia after LASIK or PRK are young age, high myopia, thin residual stromal bed, thin preoperative cornea, and abnormal preoperative contour. A young patient with a suspicious corneal contour who is considering refractive surgery should be observed over time to determine whether keratoconus will develop. See BCSC Section&#160;13, <span class="italic">Refractive Surgery, </span>for additional discussion on keratoconus.</p>
			<p class="reference-first">Feder RS. Corneal topography. In: Feder RS, ed. <span class="italic">The LASIK Handbook: A Case-based Approach.</span> 2nd&#160;ed. Philadelphia: Wolters Kluwer; 2013:32–39.</p>
			<p class="reference-mid">Rao SN, Raviv T, Majmudar PA, Epstein RJ. Role of Orbscan II in screening kerato-<br />conus suspects before refractive corneal surgery. <span class="italic">Ophthalmology.</span> 2002;109(9):<br />1642–1646.</p>
			<p class="reference-mid">Weisenthal R. Optical coherence tomography. In: Feder RS, ed. <span class="italic">The LASIK Handbook: A Case-based Approach.</span> 2nd&#160;ed. Philadelphia: Wolters Kluwer; 2013:40–46.</p>
			<p class="reference-last--no-space-">Yeu E, Belin MW, Khachikian SS. Topographic analysis in keratorefractive surgery. <br />In: Mannis MJ, Holland EJ, eds. <span class="italic">Cornea.</span> Vol&#160;1. 4th&#160;ed. Philadelphia: Elsevier; 2017:<br />1728–1735.</p>
			<p class="h5-text"><span class="h5-head">management</span> Some cases of mild keratoconus can be successfully managed with glasses. Patients should be counseled about the risk of progression with continued eye rubbing. Contact lenses can mask the associated irregular corneal astigmatism (<span class="xref-figure">Fig&#160;7-31</span>), and their use results in a dramatic improvement in vision in most cases. Although most patients will require hard or rigid gas-&#173;permeable lenses, some patients, particularly those with mild disease, may achieve improved vision and comfortable wear with soft lenses. Hybrid (gas-&#173;permeable contact lenses with a soft lens “skirt”) or scleral lenses may be helpful in more advanced disease. A central subepithelial scar can, on occasion, be removed (superficial keratectomy), allowing continued comfortable wear of contact lenses. Intrastromal corneal ring segments can be implanted to center the cone and facilitate successful contact lens wear. The procedure does not prevent progression, however, and is not intended to reduce dependence on glasses or contact lenses. Corneal crosslinking is used in patients with progressive disease. The risk of progression is greater in adolescents, who may benefit the most from this treatment. The greatest efficacy is achieved in mild to moderate cases. Corneal crosslinking may not work as well in cases of post-&#173;LASIK ectasia or in patients with more severe disease. Crosslinking may be performed in concert with intrastromal ring insertion. See BCSC Section&#160;13, <span class="italic">Refractive Surgery,</span> for additional discussion on keratoconus.</p>
			<p class="body-text">Keratoplasty becomes an important option under the following circumstances:</p>
			<ul>
				<li class="bullet-list-first">poor vision even with a comfortable contact lens fit (usually due to scarring)</li>
				<li class="bullet-list-mid">contact lens intolerance even with good vision</li>
				<li class="bullet-list-mid">unstable contact lens fit (even with good vision and tolerance)</li>
				<li class="bullet-list-mid">progressive thinning to the corneal periphery approaching the limbus, requiring a very large graft (with increased risk)</li>
				<li class="bullet-list-last">corneal hydrops that fails to clear after several months</li>
			</ul>
			<p class="body-text--no-indent-">PK is still the most widely performed surgical procedure for the treatment of keratoconus, and the prognosis is excellent. Some surgeons prefer DALK for keratoconus. Endothelial cell counts are significantly higher at 6&#160;months following DALK compared with PK. Endothelial rejection does not occur after DALK, but stromal rejection is still possible. Postostoperative wound integrity in the case of postoperative trauma is better with DALK than with PK. (See Chapter&#160;15 for further discussion of PK and DALK.)</p>
			<p class="body-text">Hydrops is treated conservatively with topical hypertonic agents and/or a soft contact lens for several months. A cycloplegic agent may be helpful for relief of pain. Aqueous suppressants may decrease the flow of fluid into the cornea. Intracameral injection of air or gas (SF<span class="subscript _idGenCharOverride-1">6</span> or C<span class="subscript _idGenCharOverride-1">3</span>F<span class="subscript _idGenCharOverride-1">8</span>) may be helpful in speeding the resolution of hydrops. Hydrops is not an indication for emergency keratoplasty.</p>
			<p class="reference-first ParaOverride-12">Feder RS, Neems LC. Noninflammatory ectatic disorders. In: Mannis MJ, Holland EJ, eds. <span class="italic">Cornea.</span> Vol&#160;1. 4th&#160;ed. Philadelphia: Elsevier; 2017:820–843.</p>
			<p class="reference-mid">Kiliç A, Colin J. Advances in the surgical treatment of keratoconus. <span class="italic">Focal Points: Clinical Modules </span><span class="italic">for Ophthalmologists.</span> San Francisco: American Academy of Ophthalmology; 2012, module&#160;2.</p>
			<p class="reference-mid">Panda A, Aggarwal A, Madhavi P, et al. Management of acute corneal hydrops secondary to keratoconus with intracameral injection of sulfur hexafluoride (SF6). <span class="italic">Cornea.</span> 2007;26(9):<br />1067–1069.</p>
			<p class="reference-mid">Raiskup-Wolf F, Hoyer A, Spoerl E, Pillunat L. Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results. <span class="italic">J&#160;Cataract Refract Surg.</span> 2008;34:<br />796–801.</p>
			<p class="reference-last--no-space-">Terry M, Ousley P. Deep lamellar endothelial keratoplasty visual acuity, astigmatism, and endothelial survival in a large prospective series. <span class="italic">Ophthalmology.</span> 2005;112(9):1541–1548.</p>
			<p class="h2 ParaOverride-4">Pellucid Marginal Degeneration</p>
			<p class="body-text--no-indent-">Pellucid marginal degeneration (PMD) is an uncommon, nonhereditary, and bilateral condition. It is associated with inferior, peripheral corneal thinning in the absence of inflammation. The etiology is unknown. PMD and keratoconus can occur in the same family or even in the same eye.</p>
			<p class="h5-text"><span class="h5-head">clinical presentation</span> Protrusion of the cornea occurs above the band of thinning (<span class="xref-figure">Fig&#160;7-32</span>), which occurs 1–2&#160;mm from the limbus and extends up to 4&#160;clock-hours. In keratoconus, the cornea protrudes at the point of maximal thinning, which is typically just below the center. In contrast, PMD is associated with peripheral thinning (<span class="xref-figure">Fig&#160;7-33</span>) and exhibits protrusion central to the area of maximum thinning. At times, a clear distinction between PMD and keratoconus is not possible. In PMD, no vascularization or lipid deposition occurs, but posterior stromal scarring has been noted within the thinned area. PMD is diagnosed in most patients between 20 and 40&#160;years of age, and men and women are affected equally. Decreased vision results from high irregular astigmatism. Acute hydrops has been reported, and, though rare, spontaneous corneal perforation has also occurred. While the “crab claw” pattern is the typical map appearance in PMD (<span class="xref-figure">Fig&#160;7-34</span>), inferior keratoconus has a similar appearance. Clinical correlation and review of elevation and pachymetric maps are important for more accurate differentiation.</p>
			<p class="h5-text"><span class="h5-head">management</span> Treatment consists of contact lens fitting early in the disease, although the fit is more difficult to achieve in PMD than in keratoconus. Hybrid or scleral lenses may be options. Eventually, PK may be required to restore vision. Because of the location of the thinning, the grafts tend to be large and close to the limbus, making surgery technically more difficult and the graft more prone to rejection. Wedge resection and lamellar tectonic grafts have been advocated as alternative or adjunctive procedures. Corneal crosslinking may also be considered for some of these patients.</p>
			<p class="reference-first">Belin MW, Asota IM, Ambrosio R Jr, Khachikian SS. What’s in a name: keratoconus, pellucid marginal degeneration, and related thinning disorders. <span class="italic">Am&#160;J Ophthalmol.</span> 2011;152(2):<br />157–162.</p>
			<p class="reference-last--no-space-">Rasheed K, Rabinowitz YS. Surgical treatment of advanced pellucid marginal degeneration. <span class="italic">Ophthalmology.</span> 2000;107(10):1836–1840.</p>
			<p class="h2">Keratoglobus</p>
			<p class="body-text--no-indent-">Keratoglobus is a rare, bilateral, noninflammatory condition that is typically present at birth, unlike keratoconus and PMD. It is usually not hereditary. Keratoglobus manifests as a globular rather than a conical deformation of the cornea (<span class="xref-figure">Fig&#160;7-35</span>).</p>
			<p class="h5-text"><span class="h5-head">pathology</span> Keratoglobus is strongly associated with blue sclerae and Ehlers-&#173;Danlos syndrome type&#160;VI (see Chapter&#160;8), and it may represent a defect in collagen synthesis. Histologically, it is characterized by an absent or fragmented Bowman layer, thinned stroma with normal lamellar organization, and a thin Descemet membrane. Unlike keratoconus, keratoglobus is not associated with atopy or hard contact lens wear.</p>
			<p class="h5-text"><span class="h5-head">clinical presentation</span> The corneas have a globular shape with a deep anterior chamber. The corneal curvature may be as steep as 50–60&#160;D, and generalized thinning appears, especially in the periphery. This is in contrast to keratoconus, which has paracentral thinning at the apex of the protrusion. Spontaneous rupture of the Descemet membrane and corneal hydrops can occur, but iron lines, stress lines, and anterior scarring are not typically seen. The corneal diameter may be slightly increased. Fleischer rings are usually not present, but prominent folds and areas of thickening in Descemet membrane are common.</p>
			<p class="h5-text"><span class="h5-head">management</span> Contact lenses, especially scleral lenses, may be of benefit. The prognosis for PK is much poorer in keratoglobus than in the other corneal ectasias. Tectonic lamellar keratoplasty followed by PK could be considered in cases requiring intervention to maintain functional vision. Spontaneous corneal rupture has been reported; thus, patients must be counseled regarding the importance of protective eyewear. High myopia is treated with spectacles to prevent amblyopia.</p>
			<p class="reference-single--no-space-">Feder RS, Neems LC. Noninflammatory ectatic disorders. In: Mannis MJ, Holland EJ, eds. <span class="italic">Cornea.</span> Vol&#160;1. 4th&#160;ed. Philadelphia: Elsevier; 2017:820–843.</p>
		</div>
		</div>
		<div id="_idContainer001" class="Basic-Text-Frame">
			<table id="table001" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-1" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-2">
						<td class="Basic-Table CellOverride-1">
							<p class="table-title"><span class="table-number">Table 7-1 </span>The IC3D Categories of Evidence for the Corneal Dystrophies</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-3">
						<td class="Basic-Table CellOverride-2">
							<p class="table-body">Category 1: A well-defined corneal dystrophy in which the gene has been mapped and identified and the specific mutations are known.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Category 2: A well-defined corneal dystrophy that has been mapped to one or more specific chromosomal loci, but the gene(s) remains to be identified.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Category 3: A well-defined corneal dystrophy in which the disorder has not yet been mapped to a chromosomal locus.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-5">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Category 4: Reserved for a suspected, new, or previously documented corneal dystrophy, although the evidence for its being a distinct entity is not yet convincing.</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-6">
							<p class="table-footnote">IC3D = International Committee for the Classification of Corneal Dystrophies.</p>
							<p class="table-source-note">Information taken from Weiss JS, Møller HU, Aldave A, et al. IC3D classification of corneal dystrophies—edition&#160;2. <span class="table-source-emphasis">Cornea.</span> 2015;34(2):119.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div id="_idContainer002" class="Basic-Text-Frame">
			<table id="table002" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-1" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-2">
						<td class="Basic-Table CellOverride-1">
							<p class="table-title"><span class="table-number">Table 7-2</span> Major Corneal Dystrophies in the IC3D Classification</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-7">
						<td class="Basic-Table CellOverride-2">
							<p class="table-head">Epithelial and subepithelial dystrophies</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body-ol1">&#9;1.&#9;Epithelial basement membrane dystrophy (EBMD): thought to be degenerative, C1 in rare cases</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body-ol1">&#9;2.&#9;Meesmann epithelial corneal dystrophy (MECD): C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body-ol1">&#9;3.&#9;Lisch epithelial corneal dystrophy (LECD): C2</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body-ol1">&#9;4.&#9;Gelatinous droplike corneal dystrophy (GDLD): C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body-ol1">&#9;5.&#9;Subepithelial mucinous corneal dystrophy (SMCD): C4</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body-ol1">&#9;6.&#9;Epithelial recurrent erosion dystrophies (EREDs): C3</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table CellOverride-7">
							<p class="table-head">Epithelial–stromal <span class="CharOverride-2">TGFBI</span> dystrophies</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body-ol1">&#9;1.&#9;Reis-Bücklers corneal dystrophy (RBCD), atypical granular corneal dystrophy: C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body-ol1">&#9;2.&#9;Thiel-Behnke corneal dystrophy (TBCD): C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body-ol1">&#9;3.&#9;Lattice corneal dystrophy</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body-ol2">a.&#9;Lattice corneal dystrophy type 1 (LCD1): C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body-ol2">b.&#9;Lattice corneal dystrophy variants (III, IIIA, I/IIIA, and IV): C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body-ol1">&#9;4.&#9;Granular corneal dystrophy</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body-ol2">a.&#9;Granular corneal dystrophy type 1 (GCD1): C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body-ol2">b.&#9;Granular corneal dystrophy type 2 (GCD2): C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table CellOverride-7">
							<p class="table-head">Stromal dystrophies</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body-ol1">&#9;1.&#9;Macular corneal dystrophy (MCD): C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body-ol1">&#9;2.&#9;Schnyder corneal dystrophy (SCD): C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body-ol1">&#9;3.&#9;Congenital stromal corneal dystrophy (CSCD): C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body-ol1">&#9;4.&#9;Fleck corneal dystrophy (FCD): C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body-ol1">&#9;5.&#9;Posterior amorphous corneal dystrophy (PACD): C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body-ol1">&#9;6.&#9;Pre-Descemet corneal dystrophy (PDCD): C1 associated with X-linked ichthyosis; C4</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table CellOverride-7">
							<p class="table-head">Endothelial dystrophies</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body-ol1">&#9;1.&#9;Fuchs endothelial corneal dystrophy (FECD): C1, C2, or C3</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body-ol1">&#9;2.&#9;Posterior polymorphous corneal dystrophy (PPCD): C1 or C2</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-10">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body-ol1">&#9;3.&#9;Congenital hereditary endothelial dystrophy (CHED): C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-6">
							<p class="table-footnote">C = category; TGFBI = transforming growth factor beta–induced.</p>
							<p class="table-source-note">Adapted with permission from Weiss JS, Møller HU, Aldave A, et al. IC3D classification of corneal dystrophies—edition&#160;2. <span class="table-source-emphasis">Cornea.</span> 2015;34(2):120.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div id="_idContainer003" class="Basic-Text-Frame">
			<table id="table003" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-11" />
					<col class="_idGenTableRowColumn-12" />
					<col class="_idGenTableRowColumn-13" />
					<col class="_idGenTableRowColumn-12" />
					<col class="_idGenTableRowColumn-14" />
					<col class="_idGenTableRowColumn-12" />
					<col class="_idGenTableRowColumn-15" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-2">
						<td class="Basic-Table CellOverride-8 _idGenCellOverride-1" colspan="7">
							<p class="table-title"><span class="table-number">Table 7-3</span> Genetics of the Major Corneal Dystrophies</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-10">
						<td class="Basic-Table CellOverride-9">
							<p class="table-column-head">Dystrophy</p>
						</td>
						<td class="Basic-Table CellOverride-9" />
						<td class="Basic-Table CellOverride-9">
							<p class="table-column-head">Gene Locus</p>
						</td>
						<td class="Basic-Table CellOverride-9" />
						<td class="Basic-Table CellOverride-9">
							<p class="table-column-head">Gene</p>
						</td>
						<td class="Basic-Table CellOverride-9" />
						<td class="Basic-Table CellOverride-9">
							<p class="table-column-head">Category</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-16">
						<td class="Basic-Table CellOverride-2">
							<p class="table-body">Epithelial basement membrane</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-body">5q31</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-body">Transforming growth factor beta–induced <span class="table-italic">(TGFBI)</span> in 2&#160;families</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-body">Sporadic in most cases, C1 in rare cases</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Meesmann</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">12q13</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Keratin K3 <span class="table-italic">(KRT3)</span></p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Stocker-Holt variant </p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">17q12</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Keratin K12 <span class="table-italic">(KRT12)</span></p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Lisch</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Xp22.3</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Unknown</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">C2</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-17">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Gelatinous droplike</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">1p32</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Tumor-associated calcium signal transducer&#160;2 <span class="table-italic">(TACSTD2)</span></p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Reis-Bücklers</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">5q31</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body"><span class="table-italic">TGFBI</span></p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Thiel-Behnke</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">5q31</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body"><span class="table-italic">TGFBI</span></p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Lattice type 1</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">5q31</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body"><span class="table-italic">TGFBI</span></p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Granular type 1</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">5q31</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body"><span class="table-italic">TGFBI</span></p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Granular type 2</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">5q31</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body"><span class="table-italic">TGFBI</span></p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Macular</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">16q22</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Carbohydrate sulfotransferase&#160;6 <span class="table-italic">(CHST6)</span></p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-17">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Schnyder</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">1p36</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">UbiA prenyltransferase domain-containing protein&#160;1 <span class="table-italic">(UBIAD1)</span></p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Congenital stromal </p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">12q21.33</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Decorin <span class="table-italic">(DCN)</span></p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-17">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Fleck</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">2q34</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Phosphoinositide kinase, FYVE finger containing–<span class="table-italic">PIKFYVE (PIKFYVE)</span></p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-18">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Posterior amorphous</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">12q21.33</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Deletion of keratocan <span class="table-italic">(KERA)</span>, lumican <span class="table-italic">(LUM)</span>, decorin <span class="table-italic">(DCN)</span>, and epiphycan <span class="table-italic">(EPYC)</span></p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Pre-Descemet</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Unknown</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Unknown</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">C1 or C4</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-18">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Fuchs</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">None (most commonly)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">None (most commonly)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">C3 (Fuchs in patients with no known inheritance)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-19">
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">13pter-q12.13 (FECD2), 18q21.2-q21.3 (FECD3), 20p13-p12 (FECD4), 5q33.1-q35.2 (FECD5), 10p11.2 (FECD6), 9p24.1-p22.1 (FECD7), 15q25 (FECD8)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Unknown, transcription factor 4 <span class="table-italic">(TCF4)</span> on chromosome&#160;18</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">C2 (Fuchs with known genetic loci but gene not yet localized)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Early-onset variant</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">1p34.3-p32</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Collagen, type&#160;VIII, alpha-2 <span class="table-italic">(COL8A2)</span></p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-17">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Posterior polymorphous: PPCD1</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">20p11.2-q11.2</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Unknown</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">C2</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">PPCD2</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">1p34.3-p32.3</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Collagen, type&#160;VIII, alpha-2 <span class="table-italic">(COL8A2)</span></p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">PPCD3</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">10p11.22</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Zinc finger E box–binding homeobox&#160;1 <span class="table-italic">(ZEB1)</span></p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Congenital hereditary endothelial<span class="CharOverride-3">*</span></p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">20p13 (telomeric portion) </p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Solute carrier family&#160;4, sodium borate transporter, member&#160;11 <span class="table-italic">(SLC4A11)</span></p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">C1</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table CellOverride-6" colspan="7">
							<p class="table-footnote">C = category.</p>
							<p class="table-footnote"><span class="table-superscript-note-ast-">*</span>Formerly divided into CHED1 and CHED2; no convincing evidence of autosomal dominant form.</p>
							<p class="table-source-note">Modified with permission from Weiss JS, Møller HU, Lisch W, et al. The IC3D classification of the corneal dystrophies. <span class="CharOverride-4">Cornea.</span> 2008;27(Suppl 2):S1–S83.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer006">
				<div id="_idContainer004" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-1</span> Epithelial basement membrane dystrophy (EBMD), seen using sclerotic scatter, demonstrates characteristic geographic maps. <span class="figure-source-note">(Courtesy of Robert S. Feder, MD.)</span></p>
				</div>
				<div id="_idContainer005" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-9418.png" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer009">
				<div id="_idContainer007" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-2</span> EBMD (seen using a broad, oblique slit beam) demonstrates geographic map areas and putty-&#173;gray opacities. <span class="figure-source-note">(Courtesy of Robert S. Feder, MD.)</span></p>
				</div>
				<div id="_idContainer008" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-9419.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer012">
				<div id="_idContainer010" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-9420.png" alt="" />
				</div>
				<div id="_idContainer011" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-3</span> <span class="figure-caption-bold">A,</span>&#160;Meesmann corneal dystrophy, appearing as tiny bubblelike blebs with indirect slit-lamp illumination. <span class="figure-caption-bold">B,</span>&#160;Blebs are also well seen against the red reflex. <span class="figure-source-note">(Part A courtesy of Robert S. Feder, MD; part&#160;B courtesy of Richard Abbott, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer015">
				<div id="_idContainer013" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-4</span> Lisch epithelial corneal dystrophy, characterized by bands of feathery, gray opacities. Retroillumination shows sectorial, densely crowded, clear microcysts in a feathery shape. <span class="figure-source-note">(Courtesy of Robert W. Weisenthal, MD.)</span></p>
				</div>
				<div id="_idContainer014" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-7731.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer018">
				<div id="_idContainer016" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-6840.png" alt="" />
				</div>
				<div id="_idContainer017" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-5</span> Gelatinous droplike corneal dystrophy. <span class="figure-caption-bold">A,</span>&#160;Mulberry type. <span class="figure-caption-bold">B,</span>&#160;Band keratopathy type. <span class="figure-caption-bold">C,</span>&#160;Kumquat-&#173;like type. <span class="figure-source-note">(Reproduced with permission from Weiss JS, Møller HU, Aldave AJ, et al. IC3D classification of corneal dystrophies—edition 2. </span><span class="figure-source-emphasis">Cornea. </span><span class="figure-source-note">2015;34(2):130).</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer021">
				<div id="_idContainer019" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/KIN00925.png" alt="" />
				</div>
				<div id="_idContainer020" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-6</span> Reis-Bücklers corneal dystrophy. <span class="figure-caption-bold">A,</span>&#160;Confocal microscopy reveals highly reflective material without shadows in the basal epithelium. <span class="figure-caption-bold">B,</span>&#160;Coarse geographic opacity of the superficial cornea. <span class="figure-caption-bold">C,</span>&#160;Broad, oblique illumination shows a dense, reticular, superficial opacity. <span class="figure-caption-bold">D,</span>&#160;Slit-lamp photograph showing irregularities at the level of the Bowman layer. <span class="figure-source-note">(Part A reproduced with permission from Weiss JS, Møller HU, Aldave AJ, et al. IC3D classification of corneal dystrophies—edition 2. </span><span class="figure-source-emphasis">Cornea. </span><span class="figure-source-note">2015;34(2):132. Parts B–D reproduced with permission from Weiss JS, Møller HU, Lisch W, et al. The IC3D classification of the corneal dystrophies. </span><span class="figure-source-emphasis">Cornea. </span><span class="figure-source-note">2008;27(suppl 2):S1–S42.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer024">
				<div id="_idContainer022" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-9423.png" alt="" />
				</div>
				<div id="_idContainer023" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-7</span> <span class="figure-caption-bold">A,</span>&#160;In vivo confocal microscopy shows that hyperreflective material is less reflective in Thiel-&#173;Behnke corneal dystrophy than in Reis-&#173;Bücklers dystrophy and reveals dark shadows&#160;in the basal epithelium not seen in Reis-&#173;Bücklers dystrophy. <span class="figure-caption-bold">B,</span>&#160;Anterior segment optical coher-<br />ence tomography shows typical hyperreflective deposits in the characteristic sawtoothed configuration at the level of the Bowman layer. <span class="figure-caption-bold">C,</span>&#160;Subepithelial reticular (honeycomb) opacities of Thiel-&#173;Behnke corneal dystrophy. <span class="figure-source-note">(Parts&#160;A and B reproduced with permission from Weiss JS, Møller HU, Aldave AJ, et al. IC3D classification of corneal dystrophies—edition 2. </span><span class="figure-source-emphasis">Cornea. </span><span class="figure-source-note">2015;34(2):134. Part C reproduced with permission from Weiss JS, Møller HU, Lisch W, et al. The IC3D classification of the corneal dystrophies. </span><span class="figure-source-emphasis">Cornea. </span><span class="figure-source-note">2008;27(suppl 2):S1–S42.)</span></p>
				</div>
			</div>
		</div>
		<div id="_idContainer025" class="Basic-Text-Frame">
			<table id="table004" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-21" />
					<col class="_idGenTableRowColumn-22" />
					<col class="_idGenTableRowColumn-23" />
					<col class="_idGenTableRowColumn-22" />
					<col class="_idGenTableRowColumn-24" />
					<col class="_idGenTableRowColumn-22" />
					<col class="_idGenTableRowColumn-25" />
					<col class="_idGenTableRowColumn-22" />
					<col class="_idGenTableRowColumn-26" />
					<col class="_idGenTableRowColumn-22" />
					<col class="_idGenTableRowColumn-24" />
					<col class="_idGenTableRowColumn-22" />
					<col class="_idGenTableRowColumn-27" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-5">
						<td class="Basic-Table CellOverride-8 _idGenCellOverride-1" colspan="13">
							<p class="table-title"><span class="table-number">Table 7-4</span> Histologic Differentiation of Granular, Lattice, Schnyder, and Macular Dystrophies</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-20">
						<td class="Basic-Table CellOverride-10">
							<p class="table-column-head">Dystrophy</p>
						</td>
						<td class="Basic-Table CellOverride-10" />
						<td class="Basic-Table CellOverride-10">
							<p class="table-column-head">Deposited Material</p>
						</td>
						<td class="Basic-Table CellOverride-10" />
						<td class="Basic-Table CellOverride-10">
							<p class="table-column-head">Masson Trichrome</p>
						</td>
						<td class="Basic-Table CellOverride-10" />
						<td class="Basic-Table CellOverride-10">
							<p class="table-column-head">Alcian Blue and Colloidal Iron</p>
						</td>
						<td class="Basic-Table CellOverride-10" />
						<td class="Basic-Table CellOverride-10">
							<p class="table-column-head">PAS</p>
						</td>
						<td class="Basic-Table CellOverride-10" />
						<td class="Basic-Table CellOverride-10">
							<p class="table-column-head">Oil red O and Sudan Black B</p>
						</td>
						<td class="Basic-Table CellOverride-10" />
						<td class="Basic-Table CellOverride-10">
							<p class="table-column-head">Congo Red</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-7">
						<td class="Basic-Table CellOverride-11">
							<p class="table-body">Granular type 1</p>
						</td>
						<td class="Basic-Table CellOverride-11" />
						<td class="Basic-Table CellOverride-11">
							<p class="table-body">Hyaline</p>
						</td>
						<td class="Basic-Table CellOverride-11" />
						<td class="Basic-Table CellOverride-11">
							<p class="table-body ParaOverride-17">+</p>
						</td>
						<td class="Basic-Table CellOverride-11" />
						<td class="Basic-Table CellOverride-11">
							<p class="table-body ParaOverride-17">–</p>
						</td>
						<td class="Basic-Table CellOverride-11" />
						<td class="Basic-Table CellOverride-11">
							<p class="table-body ParaOverride-17">–</p>
						</td>
						<td class="Basic-Table CellOverride-11" />
						<td class="Basic-Table CellOverride-11">
							<p class="table-body ParaOverride-17">–</p>
						</td>
						<td class="Basic-Table CellOverride-11" />
						<td class="Basic-Table CellOverride-11">
							<p class="table-body ParaOverride-17">–</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-17">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Granular type 2 (granular-lattice)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Hyaline, amyloid<span class="CharOverride-3">*</span></p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body ParaOverride-17">+</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body ParaOverride-17">–</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body ParaOverride-17">–</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body ParaOverride-17">–</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body ParaOverride-17">+</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Lattice type 1</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Amyloid<span class="CharOverride-3">*</span></p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body ParaOverride-17">+</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body ParaOverride-17">–</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body ParaOverride-17">+</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body ParaOverride-17">–</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body ParaOverride-17">+</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Schnyder </p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Phospholipid, cholesterol</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body ParaOverride-17">–</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body ParaOverride-17">–</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body ParaOverride-17">–</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body ParaOverride-17">+</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body ParaOverride-17">–</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-5">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Macular</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Glycosaminoglycans (acid mucopolysaccharide)</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body ParaOverride-17">–</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body ParaOverride-17">+</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body ParaOverride-17">–</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body ParaOverride-17">–</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body ParaOverride-17">–</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-28">
						<td class="Basic-Table CellOverride-6" colspan="13">
							<p class="table-footnote">PAS = periodic acid–Schiff.</p>
							<p class="table-footnote"><span class="table-superscript-note-ast-">*</span>&#9;Amyloid also stains with thioflavine T and metachromatically with crystal violet. It demonstrates dichroism and birefringence with polarizing filters.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer028">
				<div id="_idContainer026" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-8</span> In vivo confocal microscopy image demonstrates filamentous lines that correspond to corneal stromal lattice lines. <span class="figure-source-note">(Repro</span><span class="figure-source-note">duced with permission from Weiss JS, Møller HU, <br /></span><span class="figure-source-note">Aldave AJ, et al. IC3D classification of corneal dystrophies—<br /></span><span class="figure-source-note">edition 2. </span><span class="figure-source-emphasis">Cornea. </span><span class="figure-source-note">2015;34(2):136.)</span></p>
				</div>
				<div id="_idContainer027" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-9426.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer031">
				<div id="_idContainer029" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-9</span> Classic lattice corneal dystrophy (LCD1).</p>
				</div>
				<div id="_idContainer030" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-2766.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer034">
				<div id="_idContainer032" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-9427.png" alt="" />
				</div>
				<div id="_idContainer033" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-10</span> Variant lattice dystrophy type&#160;IIIA. <span class="figure-caption-bold">A,</span>&#160;Coarse linear opacities. <span class="figure-caption-bold">B,</span>&#160;Thick lattice lines are well seen on retroillumination. <span class="figure-source-note">(Courtesy of Robert S. Feder, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer037">
				<div id="_idContainer035" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-11</span> Granular corneal dystrophy type&#160;1. <span class="figure-source-note">(Courtesy of Robert S. Feder, MD.)</span></p>
				</div>
				<div id="_idContainer036" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-9430.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer040">
				<div id="_idContainer038" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-6853.png" alt="" />
				</div>
				<div id="_idContainer039" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-12</span> Granular corneal dystrophy type&#160;2. Stellate-&#173;shaped opacities with intervening clear spaces can be seen in direct illumination <span class="figure-caption-italic">(left)</span> and in retroillumination <span class="figure-caption-italic">(right).</span> <span class="figure-source-note">(Reproduced with permission from Weiss JS, Møller HU, Aldave AJ, et al. IC3D classification of corneal dystrophies—edition 2. </span><span class="figure-source-emphasis">Cornea. </span><span class="figure-source-note">2015;34(2)</span><span class="figure-source-note">:</span><span class="figure-source-note">141.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer041" class="_idGenObjectStyleOverride-1">
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer044">
				<div id="_idContainer042" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-9431.png" alt="" />
				</div>
				<div id="_idContainer043" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-13</span> Macular dystrophy. <span class="figure-caption-bold">A,</span>&#160;Diffuse illumination shows involvement to the limbus with diffuse haze. <span class="figure-caption-bold">B,</span>&#160;Slit view. Typically, the cornea is thin with dense opacities that occur more posteriorly in the periphery. <span class="figure-source-note">(Courtesy of Robert S. Feder, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer047">
				<div id="_idContainer045" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-2769.png" alt="" />
				</div>
				<div id="_idContainer046" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-14</span> Schnyder corneal dystrophy. <span class="figure-caption-bold">A,</span>&#160;Central subepithelial crystalline deposition. <span class="figure-caption-bold">B,</span>&#160;Central panstromal corneal opacity and arcus lipoides. No crystals are present. <span class="figure-source-note">(Courtesy of Jayne S. Weiss, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer050">
				<div id="_idContainer048" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-6856.png" alt="" />
				</div>
				<div id="_idContainer049" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-15</span> Congenital stromal corneal dystrophy: diffuse bilateral clouding with flakelike opacities throughout the stroma. <span class="figure-source-note">(Reproduced with permission from Weiss JS, Møller HU, Lisch W, et al. The IC3D classification of the corneal dystrophies. </span><span class="figure-source-emphasis">Cornea. </span><span class="figure-source-note">2008;27(10:Suppl 2):S22.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer053">
				<div id="_idContainer051" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-16</span> Dandrufflike opacities seen in Fleck corneal dystrophy. <span class="figure-source-note">(Reproduced with permission from Weiss JS, Møller HU, Lisch W, et al. The IC3D classification of the corneal dystrophies. </span><span class="figure-source-emphasis">Cornea. </span><span class="figure-source-note">2008;27(10:Suppl 2):S23.)</span></p>
				</div>
				<div id="_idContainer052" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-6857.png" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer056">
				<div id="_idContainer054" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-9434.png" alt="" />
				</div>
				<div id="_idContainer055" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-17</span> Posterior amorphous corneal dystrophy. <span class="figure-caption-bold">A,</span>&#160;Central, deep stromal pre-&#173;Descemet opacity. <span class="figure-caption-bold">B,</span>&#160;Slit-lamp photograph shows a diffusely thin, flat cornea with a posterior stromal&#160;opacity. <span class="figure-source-note">(Part A reproduced with permission from Weiss JS, Møller HU, Lisch W, et al. The IC3D classification of the corneal dystrophies. </span><span class="figure-source-emphasis">Cornea. </span><span class="figure-source-note">2008;27(Suppl 2):S24.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer059">
				<div id="_idContainer057" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-9436.jpg" alt="" />
				</div>
				<div id="_idContainer058" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-18</span> Pre-&#173;Descemet corneal dystrophy: punctate opacities just anterior to the Descemet membrane. <span class="figure-source-note">(Courtesy of Robert&#160;S. Feder, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer062">
				<div id="_idContainer060" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-9437.png" alt="" />
				</div>
				<div id="_idContainer061" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-19</span> Fuchs endothelial corneal dystrophy. Cornea guttae are seen with indirect illumination over the iris and with the red reflex. <span class="figure-source-note">(Courtesy of Robert S. Feder, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer065">
				<div id="_idContainer063" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-2748.jpg" alt="" />
				</div>
				<div id="_idContainer064" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-20</span> Fuchs endothelial corneal dystrophy showing the “beaten metal” appearance of the endothelium with mild stromal edema. <span class="figure-source-note">(Courtesy of Vincent P. deLuise, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer068">
				<div id="_idContainer066" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-9438.png" alt="" />
				</div>
				<div id="_idContainer067" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-21</span> Findings in posterior polymorphous corneal dystrophy. <span class="figure-caption-bold">A,</span>&#160;Broad, oblique view shows clusters of endothelial vesicles, which are commonly seen. <span class="figure-caption-bold">B,</span>&#160;Scallop-&#173;edged endothelial band <span class="figure-caption-italic">(arrow).</span> <span class="figure-source-note">(Part A courtesy of Robert S. Feder, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer071">
				<div id="_idContainer069" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-2751.png" alt="" />
				</div>
				<div id="_idContainer070" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-22</span> Posterior polymorphous corneal dystrophy showing iridocorneal adhesion and corectopia.</p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer074">
				<div id="_idContainer072" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-9440.png" alt="" />
				</div>
				<div id="_idContainer073" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-23</span> Congenital hereditary endothelial dystrophy. <span class="figure-caption-bold">A,</span>&#160;Milky appearance of the cornea with diffuse illumination. <span class="figure-caption-bold">B,</span>&#160;Slit view shows diffuse stromal thickening. <span class="figure-source-note">(Reproduced with permission from Weiss JS, Møller H, Aldave A, et al. IC3D classification of corneal dystrophies—edition 2. </span><span class="figure-source-emphasis">Cornea. </span><span class="figure-source-note">2015;34(2):156.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer077">
				<div id="_idContainer075" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-2752.jpg" alt="" />
				</div>
				<div id="_idContainer076" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-24</span> Keratoconus. Note the marked corneal protrusion, a hallmark of keratoconus.</p>
				</div>
			</div>
		</div>
		<div id="_idContainer078" class="Basic-Text-Frame">
			<p class="figure-caption"><span class="figure-number">Figure 7-25</span> Broad, oblique slit-lamp image (high magnification). Breaks at the level of the Bowman layer <span class="figure-caption-italic">(white arrow)</span> are apparent.&#160;The <span class="figure-caption-italic">black arrow</span> indicates where collagen has presumably filled in a previous break. Vogt striae are also seen. This is the mechanism of the superficial reticular scarring seen in keratoconus. <span class="figure-source-note">(Reprinted from Shapiro MB, Rodrigues MM, Mandel MR, Krachmer JH. Anterior clear spaces in keratoconus. </span><span class="figure-source-emphasis">Ophthalmology.</span><span class="figure-source-note"> 1986;93(10):1316–1319.)</span></p>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer079" class="_idGenObjectStyleOverride-1">
				<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-9442.png" alt="" />
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer082">
				<div id="_idContainer080" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-9443.png" alt="" />
				</div>
				<div id="_idContainer081" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-26</span> Munson sign. Note the angulation of the lower eyelid with the eye in downgaze. <span class="figure-source-note">(Courtesy of Woodford S. Van Meter, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer085">
				<div id="_idContainer083" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-6865.png" alt="" />
				</div>
				<div id="_idContainer084" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-27</span> Fleischer ring <span class="figure-caption-italic">(arrow),</span> demonstrated using diffuse illumination with a cobalt-&#173;blue filter. <span class="figure-source-note">(Courtesy of James J. Reidy, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer088">
				<div id="_idContainer086" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-28</span> Vogt striae are fine folds in the posterior stroma at the cone apex. Striae become less apparent when external pressure is applied. <span class="figure-source-note">(Courtesy of Robert S. Feder, MD.)</span></p>
				</div>
				<div id="_idContainer087" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-9444.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer091">
				<div id="_idContainer089" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-29</span> Corneal edema in keratoconus due to a sudden rupture of the Descemet membrane (acute hydrops). <span class="figure-source-note">(Courtesy of Rob</span><span class="figure-source-note">ert&#160;S. Feder, MD.)</span></p>
				</div>
				<div id="_idContainer090" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-9445.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer094">
				<div id="_idContainer092" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-9446.jpg" alt="" />
				</div>
				<div id="_idContainer093" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-30</span> Corneal contour map. <span class="figure-caption-italic">Upper left:</span> Scheimpflug-&#173;based imaging illustrates a power map with inferior steepening and superior flattening. <span class="figure-caption-italic">Upper right:</span> An isolated island of anterior elevation above a best-fit sphere coincident with the maximum steepness. <span class="figure-caption-italic">Lower right:</span> An isolated island of posterior elevation. <span class="figure-caption-italic">Lower left:</span> Marked thinning in an area coincident with steepening and elevation. <span class="figure-source-note">(Courtesy of Robert S. Feder, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer097">
				<div id="_idContainer095" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-9447.png" alt="" />
				</div>
				<div id="_idContainer096" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-31</span> Hard contact lens effect on the keratoconus power map; with lens <span class="figure-caption-italic">(right side)</span> and without lens <span class="figure-caption-italic">(left side).</span> <span class="figure-caption-italic">Upper left:</span> Apical scarring has resulted in flattening, as noted in the power map. <span class="figure-caption-italic">Lower left:</span> The corresponding videokeratoscopic image is irregular, and the rings are widely spaced. <span class="figure-caption-italic">Upper right:</span> The power map appears much more normal when acquired with the patient wearing a contact lens. <span class="figure-caption-italic">Lower right:</span> The videokeratoscopic image is also much more regular, with narrower spacing. <span class="figure-source-note">(Courtesy of Robert S. Feder, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer100">
				<div id="_idContainer098" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-32</span> Typically in pellucid marginal degeneration there is inferior protrusion of the cornea above the band of thinning, which occurs 1–2&#160;mm from the limbus and extends up to 4&#160;clock-hours. <span class="figure-source-note">(Courtesy of Vincent P. deLuise, MD.)</span></p>
				</div>
				<div id="_idContainer099" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-2757.jpg" alt="" />
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer103">
				<div id="_idContainer101" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-9448.jpg" alt="" />
				</div>
				<div id="_idContainer102" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-33</span> Slit view demonstrates protrusion of the cornea above a band of stromal thinning in pellucid marginal degeneration. <span class="figure-source-note">(Reproduced with permission from Feder RS, Neems LC. Noninflammatory ectatic disorders. In: Mannis MJ, Ho</span><span class="figure-source-note">l</span><span class="figure-source-note">land EJ, eds. </span><span class="figure-source-emphasis">Cornea. </span><span class="figure-source-note">Vol 1. 4th&#160;ed. Philadelphia: Elsevier; 2017:836.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer106">
				<div id="_idContainer104" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-9449.jpg" alt="" />
				</div>
				<div id="_idContainer105" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-34</span> Power map shows the typical “crab claw” pattern seen in pellucid marginal degeneration, which can also be seen in keratoconus with inferior apical decentration. <span class="figure-source-note">(Courtesy of Robert S. Feder, MD.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer109">
				<div id="_idContainer107" class="_idGenObjectStyleOverride-1">
					<img class="_idGenObjectAttribute-1" src="BCSC2017-2018_S08_ch07_p133-172-web-resources/image/AAX-6867.png" alt="" />
				</div>
				<div id="_idContainer108" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 7-35</span> The presence of corneal thinning and the type of contour abnormality can be helpful to the clinician in recognizing the type of ectatic disorder. <span class="figure-caption-bold">A,</span>&#160;Keratoconus. <span class="figure-caption-bold">B,</span>&#160;Pellucid marginal degeneration. <span class="figure-caption-bold">C,</span>&#160;Keratoglobus. <span class="figure-source-note">(Reproduced with permission from Feder RS, Neems LC. Noninfla</span><span class="figure-source-note">m</span><span class="figure-source-note">matory ectatic disorders. In: Mannis MJ, Holland EJ, eds. </span><span class="figure-source-emphasis">Cornea. </span><span class="figure-source-note">Vol 1. 4th&#160;ed. Philadelphia: Elsevier; 2017:822.)</span></p>
				</div>
			</div>
		</div>
	</body>
</html>
